                               SEQUENCE LISTING	

<110> GENENTECH, INC. et al. 
 
<120> HUMANIZED ANTI-EGFL7 ANTIBODIES AND METHODS USING SAME

<130> P4328R1 WO

<140>
<141>

<150> 61/176,817
<151> 2009-05-08

<160> 233   

<170> PatentIn version 3.5

<210> 1
<211> 278
<212> PRT
<213> Mus sp.

<400> 1
Met Gln Thr Met Trp Gly Ser Gly Glu Leu Leu Val Ala Trp Phe Leu 
1               5                   10                  15      


Val Leu Ala Ala Asp Gly Thr Thr Glu His Val Tyr Arg Pro Ser Arg 
            20                  25                  30          


Arg Val Cys Thr Val Gly Ile Ser Gly Gly Ser Ile Ser Glu Thr Phe 
        35                  40                  45              


Val Gln Arg Val Tyr Gln Pro Tyr Leu Thr Thr Cys Asp Gly His Arg 
    50                  55                  60                  


Ala Cys Ser Thr Tyr Arg Thr Ile Tyr Arg Thr Ala Tyr Arg Arg Ser 
65                  70                  75                  80  


Pro Gly Val Thr Pro Ala Arg Pro Arg Tyr Ala Cys Cys Pro Gly Trp 
                85                  90                  95      


Lys Arg Thr Ser Gly Leu Pro Gly Ala Cys Gly Ala Ala Ile Cys Gln 
            100                 105                 110         


Pro Pro Cys Gly Asn Gly Gly Ser Cys Ile Arg Pro Gly His Cys Arg 
        115                 120                 125             


Cys Pro Val Gly Trp Gln Gly Asp Thr Cys Gln Thr Asp Val Asp Glu 
    130                 135                 140                 


Cys Ser Thr Gly Glu Ala Ser Cys Pro Gln Arg Cys Val Asn Thr Val 
145                 150                 155                 160 


Gly Ser Tyr Trp Cys Gln Gly Trp Glu Gly Gln Ser Pro Ser Ala Asp 
                165                 170                 175     


Gly Thr Arg Cys Leu Ser Lys Glu Gly Pro Ser Pro Val Ala Pro Asn 
            180                 185                 190         


Pro Thr Ala Gly Val Asp Ser Met Ala Arg Glu Glu Val Tyr Arg Leu 
        195                 200                 205             


Gln Ala Arg Val Asp Val Leu Glu Gln Lys Leu Gln Leu Val Leu Ala 
    210                 215                 220                 


Pro Leu His Ser Leu Ala Ser Arg Ser Thr Glu His Gly Leu Gln Asp 
225                 230                 235                 240 


Pro Gly Ser Leu Leu Ala His Ser Phe Gln Gln Leu Asp Arg Ile Asp 
                245                 250                 255     


Ser Leu Ser Glu Gln Val Ser Phe Leu Glu Glu His Leu Gly Ser Cys 
            260                 265                 270         


Ser Cys Lys Lys Asp Leu 
        275             


<210> 2
<211> 274
<212> PRT
<213> Homo sapiens

<400> 2
Met Arg Gly Ser Gln Glu Val Leu Leu Met Trp Leu Leu Val Leu Ala 
1               5                   10                  15      


Val Gly Gly Thr Glu His Ala Tyr Arg Pro Gly Arg Arg Val Cys Ala 
            20                  25                  30          


Val Arg Ala His Gly Asp Pro Val Ser Glu Ser Phe Val Gln Arg Val 
        35                  40                  45              


Tyr Gln Pro Phe Leu Thr Thr Cys Asp Gly His Arg Ala Cys Ser Thr 
    50                  55                  60                  


Tyr Arg Thr Ile Tyr Arg Thr Ala Tyr Arg Arg Ser Pro Gly Leu Ala 
65                  70                  75                  80  


Pro Ala Arg Pro Arg Tyr Ala Cys Cys Pro Gly Trp Lys Arg Thr Ser 
                85                  90                  95      


Gly Leu Pro Gly Ala Cys Gly Ala Ala Ile Cys Gln Pro Pro Cys Arg 
            100                 105                 110         


Asn Gly Gly Ser Cys Val Gln Pro Gly Arg Cys Arg Cys Pro Ala Gly 
        115                 120                 125             


Trp Arg Gly Asp Thr Cys Gln Ser Asp Val Asp Glu Cys Ser Ala Arg 
    130                 135                 140                 


Arg Gly Gly Cys Pro Gln Arg Cys Ile Asn Thr Ala Gly Ser Tyr Trp 
145                 150                 155                 160 


Cys Gln Cys Trp Glu Gly His Ser Leu Ser Ala Asp Gly Thr Leu Cys 
                165                 170                 175     


Val Pro Lys Gly Gly Pro Pro Arg Val Ala Pro Asn Pro Thr Gly Val 
            180                 185                 190         


Asp Ser Ala Met Lys Glu Glu Val Gln Arg Leu Gln Ser Arg Val Asp 
        195                 200                 205             


Leu Leu Glu Glu Lys Leu Gln Leu Val Leu Ala Pro Leu His Ser Leu 
    210                 215                 220                 


Ala Ser Gln Ala Leu Glu His Gly Leu Pro Asp Pro Gly Ser Leu Leu 
225                 230                 235                 240 


Val His Ser Phe Gln Gln Leu Gly Arg Ile Asp Ser Leu Ser Glu Gln 
                245                 250                 255     


Ile Ser Phe Leu Glu Glu Gln Leu Gly Ser Cys Ser Cys Lys Lys Asp 
            260                 265                 270         


Ser Gly 
        


<210> 3
<211> 26
<212> PRT
<213> Artificial Sequence

<220>
<221> source
<223> /note="Description of Artificial Sequence: Synthetic
      peptide"

<400> 3
Leu Thr Thr Cys Asp Gly His Arg Ala Cys Ser Thr Tyr Arg Thr Ile 
1               5                   10                  15      


Tyr Arg Thr Ala Tyr Arg Arg Ser Pro Gly 
            20                  25      


<210> 4
<211> 30
<212> PRT
<213> Artificial Sequence

<220>
<221> source
<223> /note="Description of Artificial Sequence: Synthetic
      polypeptide"

<400> 4
Pro Ala Arg Pro Arg Tyr Ala Cys Cys Pro Gly Trp Lys Arg Thr Ser 
1               5                   10                  15      


Gly Leu Pro Gly Ala Cys Gly Ala Ala Ile Cys Gln Pro Pro 
            20                  25                  30  


<210> 5
<211> 13
<212> PRT
<213> Artificial Sequence

<220>
<221> source
<223> /note="Description of Artificial Sequence: Synthetic
      peptide"

<400> 5
Arg Pro Arg Tyr Ala Cys Cys Pro Gly Trp Lys Arg Thr 
1               5                   10              


<210> 6
<211> 13
<212> PRT
<213> Artificial Sequence

<220>
<221> source
<223> /note="Description of Artificial Sequence: Synthetic
      peptide"

<400> 6
Leu Thr Thr Cys Asp Gly His Arg Ala Cys Ser Thr Tyr 
1               5                   10              


<210> 7
<211> 13
<212> PRT
<213> Artificial Sequence

<220>
<221> source
<223> /note="Description of Artificial Sequence: Synthetic
      peptide"

<400> 7
Arg Ala Cys Ser Thr Tyr Arg Thr Ile Tyr Arg Thr Ala 
1               5                   10              


<210> 8
<211> 13
<212> PRT
<213> Artificial Sequence

<220>
<221> source
<223> /note="Description of Artificial Sequence: Synthetic
      peptide"

<400> 8
Arg Thr Ala Tyr Arg Arg Ser Pro Gly Val Thr Pro Ala 
1               5                   10              


<210> 9
<211> 108
<212> PRT
<213> Artificial Sequence

<220>
<221> source
<223> /note="Description of Artificial Sequence: Synthetic
      polypeptide"

<400> 9
Asp Ile Gln Met Thr Gln Ser Pro Ser Ser Leu Ser Ala Ser Val Gly 
1               5                   10                  15      


Asp Arg Val Thr Ile Thr Cys Arg Ala Ser Gln Ser Ile Ser Asn Tyr 
            20                  25                  30          


Leu Ala Trp Tyr Gln Gln Lys Pro Gly Lys Ala Pro Lys Leu Leu Ile 
        35                  40                  45              


Tyr Ala Ala Ser Ser Leu Glu Ser Gly Val Pro Ser Arg Phe Ser Gly 
    50                  55                  60                  


Ser Gly Ser Gly Thr Asp Phe Thr Leu Thr Ile Ser Ser Leu Gln Pro 
65                  70                  75                  80  


Glu Asp Phe Ala Thr Tyr Tyr Cys Gln Gln Tyr Asn Ser Leu Pro Trp 
                85                  90                  95      


Thr Phe Gly Gln Gly Thr Lys Val Glu Ile Lys Arg 
            100                 105             


<210> 10
<211> 112
<212> PRT
<213> Homo sapiens

<400> 10
Asp Ile Gln Met Thr Gln Ser Pro Ser Ser Leu Ser Ala Ser Val Gly 
1               5                   10                  15      


Asp Arg Val Thr Ile Thr Cys Lys Ala Ser Gln Ser Val Asp Tyr Asp 
            20                  25                  30          


Gly Asp Ser Tyr Met Ser Trp Tyr Gln Gln Lys Pro Gly Lys Ala Pro 
        35                  40                  45              


Lys Leu Leu Ile Tyr Gly Ala Ser Asn Leu Glu Ser Gly Val Pro Ser 
    50                  55                  60                  


Arg Phe Ser Gly Ser Gly Ser Gly Thr Asp Phe Thr Leu Thr Ile Ser 
65                  70                  75                  80  


Ser Leu Gln Pro Glu Asp Phe Ala Thr Tyr Tyr Cys Gln Gln Asn Asn 
                85                  90                  95      


Glu Asp Pro Tyr Thr Phe Gly Gln Gly Thr Lys Val Glu Ile Lys Arg 
            100                 105                 110         


<210> 11
<211> 113
<212> PRT
<213> Artificial Sequence

<220>
<221> source
<223> /note="Description of Artificial Sequence: Synthetic
      polypeptide"

<400> 11
Glu Val Gln Leu Val Glu Ser Gly Gly Gly Leu Val Gln Pro Gly Gly 
1               5                   10                  15      


Ser Leu Arg Leu Ser Cys Ala Ala Ser Gly Phe Thr Phe Ser Ser Tyr 
            20                  25                  30          


Ala Met Ser Trp Val Arg Gln Ala Pro Gly Lys Gly Leu Glu Trp Val 
        35                  40                  45              


Ser Val Ile Ser Gly Asp Gly Gly Ser Thr Tyr Tyr Ala Asp Ser Val 
    50                  55                  60                  


Lys Gly Arg Phe Thr Ile Ser Arg Asp Asn Ser Lys Asn Thr Leu Tyr 
65                  70                  75                  80  


Leu Gln Met Asn Ser Leu Arg Ala Glu Asp Thr Ala Val Tyr Tyr Cys 
                85                  90                  95      


Ala Arg Gly Phe Asp Tyr Trp Gly Gln Gly Thr Leu Val Thr Val Ser 
            100                 105                 110         


Ser 
    


<210> 12
<211> 117
<212> PRT
<213> Homo sapiens

<400> 12
Glu Val Gln Leu Val Glu Ser Gly Gly Gly Leu Val Gln Pro Gly Gly 
1               5                   10                  15      


Ser Leu Arg Leu Ser Cys Ala Ala Ser Gly His Thr Phe Thr Thr Tyr 
            20                  25                  30          


Gly Met Ser Trp Val Arg Gln Ala Pro Gly Lys Gly Leu Glu Trp Val 
        35                  40                  45              


Gly Trp Ile Asn Thr His Ser Gly Val Pro Thr Tyr Ala Asp Asp Phe 
    50                  55                  60                  


Lys Gly Arg Phe Thr Ile Ser Arg Asp Asn Ser Lys Asn Thr Leu Tyr 
65                  70                  75                  80  


Leu Gln Met Asn Ser Leu Arg Ala Glu Asp Thr Ala Val Tyr Tyr Cys 
                85                  90                  95      


Ala Arg Leu Gly Ser Ser Ala Val Asp Tyr Trp Gly Gln Gly Thr Leu 
            100                 105                 110         


Val Thr Val Ser Ser 
        115     


<210> 13
<211> 39
<212> DNA
<213> Artificial Sequence

<220>
<221> source
<223> /note="Description of Artificial Sequence: Synthetic
      oligonucleotide"


<220>
<221> CDS
<222> (1)..(39)

<400> 13
gcc tat gca gat atc cag atg acc cag tcc ccg agc tcc                     39
Ala Tyr Ala Asp Ile Gln Met Thr Gln Ser Pro Ser Ser                       
1               5                   10                                    


<210> 14
<211> 13
<212> PRT
<213> Artificial Sequence

<220>
<221> source
<223> /note="Description of Artificial Sequence: Synthetic
      peptide"

<400> 14
Ala Tyr Ala Asp Ile Gln Met Thr Gln Ser Pro Ser Ser 
1               5                   10              


<210> 15
<211> 10
<212> PRT
<213> Artificial Sequence

<220>
<221> source
<223> /note="Description of Artificial Sequence: Synthetic
      peptide"

<400> 15
Asp Ile Val Leu Thr Gln Ser Pro Ala Ser 
1               5                   10  


<210> 16
<211> 39
<212> DNA
<213> Artificial Sequence

<220>
<221> source
<223> /note="Description of Artificial Sequence: Synthetic
      oligonucleotide"

<400> 16
gcctatcgag atatccagmt cacccagtcc ccgagctcc                              39


<210> 17
<211> 39
<212> DNA
<213> Artificial Sequence

<220>
<221> source
<223> /note="Description of Artificial Sequence: Synthetic
      oligonucleotide"


<220>
<221> CDS
<222> (1)..(39)

<400> 17
aca aac gcg tac gct gag gtt cag ctg gtg gag tct ggc                     39
Thr Asn Ala Tyr Ala Glu Val Gln Leu Val Glu Ser Gly                       
1               5                   10                                    


<210> 18
<211> 13
<212> PRT
<213> Artificial Sequence

<220>
<221> source
<223> /note="Description of Artificial Sequence: Synthetic
      peptide"

<400> 18
Thr Asn Ala Tyr Ala Glu Val Gln Leu Val Glu Ser Gly 
1               5                   10              


<210> 19
<211> 8
<212> PRT
<213> Artificial Sequence

<220>
<221> source
<223> /note="Description of Artificial Sequence: Synthetic
      peptide"

<400> 19
Gln Ile Gln Leu Val Gln Ser Gly 
1               5               


<210> 20
<211> 39
<212> DNA
<213> Artificial Sequence

<220>
<221> source
<223> /note="Description of Artificial Sequence: Synthetic
      oligonucleotide"

<400> 20
acaaacgcgt acgctgagrt ccagctggtg gagtctggc                              39


<210> 21
<211> 36
<212> DNA
<213> Artificial Sequence

<220>
<221> source
<223> /note="Description of Artificial Sequence: Synthetic
      oligonucleotide"


<220>
<221> CDS
<222> (1)..(36)

<400> 21
ggt aag ggc ctg gaa tgg gtt gca agg att tat cct                         36
Gly Lys Gly Leu Glu Trp Val Ala Arg Ile Tyr Pro                           
1               5                   10                                    


<210> 22
<211> 12
<212> PRT
<213> Artificial Sequence

<220>
<221> source
<223> /note="Description of Artificial Sequence: Synthetic
      peptide"

<400> 22
Gly Lys Gly Leu Glu Trp Val Ala Arg Ile Tyr Pro 
1               5                   10          


<210> 23
<211> 12
<212> PRT
<213> Artificial Sequence

<220>
<221> source
<223> /note="Description of Artificial Sequence: Synthetic
      peptide"

<400> 23
Gly Lys Gly Leu Lys Trp Met Gly Trp Ile Asn Thr 
1               5                   10          


<210> 24
<211> 36
<212> DNA
<213> Artificial Sequence

<220>
<221> source
<223> /note="Description of Artificial Sequence: Synthetic
      oligonucleotide"

<400> 24
ggtaagggcc tggaatggrt ggcaaggatt tatcct                                 36


<210> 25
<211> 102
<212> DNA
<213> Artificial Sequence

<220>
<221> source
<223> /note="Description of Artificial Sequence: Synthetic
      polynucleotide"


<220>
<221> CDS
<222> (1)..(102)

<400> 25
gtc aag ggc cgt ttc act ata agc cgc gac aac tcc aaa aac aca ctg         48
Val Lys Gly Arg Phe Thr Ile Ser Arg Asp Asn Ser Lys Asn Thr Leu           
1               5                   10                  15                

tac cta caa atg aac agc gag gac act gcc gtc tat tat tgt agc cgc         96
Tyr Leu Gln Met Asn Ser Glu Asp Thr Ala Val Tyr Tyr Cys Ser Arg           
            20                  25                  30                    

tgg gga                                                                102
Trp Gly                                                                   


<210> 26
<211> 34
<212> PRT
<213> Artificial Sequence

<220>
<221> source
<223> /note="Description of Artificial Sequence: Synthetic
      polypeptide"

<400> 26
Val Lys Gly Arg Phe Thr Ile Ser Arg Asp Asn Ser Lys Asn Thr Leu 
1               5                   10                  15      


Tyr Leu Gln Met Asn Ser Glu Asp Thr Ala Val Tyr Tyr Cys Ser Arg 
            20                  25                  30          


Trp Gly 
        


<210> 27
<211> 34
<212> PRT
<213> Artificial Sequence

<220>
<221> source
<223> /note="Description of Artificial Sequence: Synthetic
      polypeptide"


<400> 27
Phe Lys Gly Arg Phe Ala Phe Ser Leu Glu Thr Ser Ala Ser Thr Ala 
1               5                   10                  15      


His Leu Gln Ile Asn Asn Glu Asp Thr Ala Thr Tyr Phe Cys Ala Arg 
            20                  25                  30          


Leu Gly 
        


<210> 28
<211> 102
<212> DNA
<213> Artificial Sequence

<220>
<221> source
<223> /note="Description of Artificial Sequence: Synthetic
      polynucleotide"

<400> 28
gtcaagggcc gtttcactwt cagcckcgac amctccrmaa rcacarygta cctacaaatg       60

aacagcgagg acactgccgt ctattwctgt gcgcgtctgg gt                         102


<210> 29
<211> 13
<212> PRT
<213> Artificial Sequence

<220>
<221> source
<223> /note="Description of Artificial Sequence: Synthetic
      peptide"

<400> 29
Arg Ser Pro Gly Leu Ala Pro Ala Arg Pro Arg Tyr Ala 
1               5                   10              


<210> 30
<211> 13
<212> PRT
<213> Artificial Sequence

<220>
<221> source
<223> /note="Description of Artificial Sequence: Synthetic
      peptide"

<400> 30
Gly Trp Lys Arg Thr Ser Gly Leu Pro Gly Ala Cys Gly 
1               5                   10              


<210> 31
<211> 15
<212> PRT
<213> Artificial Sequence

<220>
<221> source
<223> /note="Description of Artificial Sequence: Synthetic
      peptide"

<400> 31
Lys Ala Ser Gln Ser Val Asp Tyr Asp Gly Asp Ser Tyr Met Ser 
1               5                   10                  15  


<210> 32
<211> 7
<212> PRT
<213> Artificial Sequence

<220>
<221> source
<223> /note="Description of Artificial Sequence: Synthetic
      peptide"

<400> 32
Gly Ala Ser Asn Leu Glu Ser 
1               5           


<210> 33
<211> 9
<212> PRT
<213> Artificial Sequence

<220>
<221> source
<223> /note="Description of Artificial Sequence: Synthetic
      peptide"

<400> 33
Gln Gln Asn Asn Glu Asp Pro Tyr Thr 
1               5                   


<210> 34
<211> 10
<212> PRT
<213> Artificial Sequence

<220>
<221> source
<223> /note="Description of Artificial Sequence: Synthetic
      peptide"

<400> 34
Gly His Thr Phe Thr Thr Tyr Gly Met Ser 
1               5                   10  


<210> 35
<211> 18
<212> PRT
<213> Artificial Sequence

<220>
<221> source
<223> /note="Description of Artificial Sequence: Synthetic
      peptide"

<400> 35
Gly Trp Ile Asn Thr His Ser Gly Val Pro Thr Tyr Ala Asp Asp Phe 
1               5                   10                  15      


Lys Gly 
        


<210> 36
<211> 10
<212> PRT
<213> Artificial Sequence

<220>
<221> source
<223> /note="Description of Artificial Sequence: Synthetic
      peptide"

<400> 36
Ala Arg Leu Gly Ser Ser Ala Val Asp Tyr 
1               5                   10  


<210> 37
<211> 15
<212> PRT
<213> Artificial Sequence

<220>
<221> source
<223> /note="Description of Artificial Sequence: Synthetic
      peptide"

<400> 37
Lys Arg Ser Gln Ser Val Asp Tyr Asp Gly Asp Ser Tyr Met Ser 
1               5                   10                  15  


<210> 38
<211> 15
<212> PRT
<213> Artificial Sequence

<220>
<221> source
<223> /note="Description of Artificial Sequence: Synthetic
      peptide"

<400> 38
Lys Ala Ser His Ser Val Asp Tyr Asp Gly Asp Ser Tyr Met Ser 
1               5                   10                  15  


<210> 39
<211> 15
<212> PRT
<213> Artificial Sequence

<220>
<221> source
<223> /note="Description of Artificial Sequence: Synthetic
      peptide"

<400> 39
Lys Ala Ser Gln Ser Gly Asp Tyr Asp Gly Asp Ser Tyr Met Ser 
1               5                   10                  15  


<210> 40
<211> 15
<212> PRT
<213> Artificial Sequence

<220>
<221> source
<223> /note="Description of Artificial Sequence: Synthetic
      peptide"

<400> 40
Lys Ala Ser Gln Ser Val Asp Tyr Arg Gly Asp Ser Tyr Met Ser 
1               5                   10                  15  


<210> 41
<211> 15
<212> PRT
<213> Artificial Sequence

<220>
<221> source
<223> /note="Description of Artificial Sequence: Synthetic
      peptide"

<400> 41
Lys Ala Ser Gln Ser Val Asp Tyr Asp Gly Asp Ser Tyr Val Ser 
1               5                   10                  15  


<210> 42
<211> 15
<212> PRT
<213> Artificial Sequence

<220>
<221> source
<223> /note="Description of Artificial Sequence: Synthetic
      peptide"

<400> 42
Lys Ala Ser Gln Ser Val Asp Tyr Leu Gly Asp Ser Tyr Met Ser 
1               5                   10                  15  


<210> 43
<211> 15
<212> PRT
<213> Artificial Sequence

<220>
<221> source
<223> /note="Description of Artificial Sequence: Synthetic
      peptide"

<400> 43
Lys Ala Ser Gln Ser Val Asp Tyr Trp Gly Asp Ser Tyr Met Ser 
1               5                   10                  15  


<210> 44
<211> 7
<212> PRT
<213> Artificial Sequence

<220>
<221> source
<223> /note="Description of Artificial Sequence: Synthetic
      peptide"

<400> 44
Gly Ala Ser Tyr Leu Glu Ser 
1               5           


<210> 45
<211> 7
<212> PRT
<213> Artificial Sequence

<220>
<221> source
<223> /note="Description of Artificial Sequence: Synthetic
      peptide"

<400> 45
Gly Ala Ser Asn Arg Glu Ser 
1               5           


<210> 46
<211> 7
<212> PRT
<213> Artificial Sequence

<220>
<221> source
<223> /note="Description of Artificial Sequence: Synthetic
      peptide"

<400> 46
Gly Ala Ser Asn Tyr Glu Ser 
1               5           


<210> 47
<211> 7
<212> PRT
<213> Artificial Sequence

<220>
<221> source
<223> /note="Description of Artificial Sequence: Synthetic
      peptide"

<400> 47
Gly Ala Ser Asn Leu Glu Gln 
1               5           


<210> 48
<211> 9
<212> PRT
<213> Artificial Sequence

<220>
<221> source
<223> /note="Description of Artificial Sequence: Synthetic
      peptide"

<400> 48
Gln Gln Asn Asn Glu Asp Pro Phe Thr 
1               5                   


<210> 49
<211> 10
<212> PRT
<213> Artificial Sequence

<220>
<221> source
<223> /note="Description of Artificial Sequence: Synthetic
      peptide"

<400> 49
Gly His Thr Gly Thr Thr Tyr Gly Met Ser 
1               5                   10  


<210> 50
<211> 10
<212> PRT
<213> Artificial Sequence

<220>
<221> source
<223> /note="Description of Artificial Sequence: Synthetic
      peptide"

<400> 50
Gly His Thr Phe Thr Thr Tyr Gly Tyr Ser 
1               5                   10  


<210> 51
<211> 10
<212> PRT
<213> Artificial Sequence

<220>
<221> source
<223> /note="Description of Artificial Sequence: Synthetic
      peptide"

<400> 51
Gly His Thr Phe Asp Thr Tyr Gly Met Ser 
1               5                   10  


<210> 52
<211> 10
<212> PRT
<213> Artificial Sequence

<220>
<221> source
<223> /note="Description of Artificial Sequence: Synthetic
      peptide"

<400> 52
Gly His Thr Phe Arg Thr Tyr Gly Met Ser 
1               5                   10  


<210> 53
<211> 10
<212> PRT
<213> Artificial Sequence

<220>
<221> source
<223> /note="Description of Artificial Sequence: Synthetic
      peptide"

<400> 53
Gly Val Thr Phe Thr Thr Tyr Gly Met Ser 
1               5                   10  


<210> 54
<211> 10
<212> PRT
<213> Artificial Sequence

<220>
<221> source
<223> /note="Description of Artificial Sequence: Synthetic
      peptide"

<400> 54
Gly His Arg Phe Thr Thr Tyr Gly Met Ser 
1               5                   10  


<210> 55
<211> 10
<212> PRT
<213> Artificial Sequence

<220>
<221> source
<223> /note="Description of Artificial Sequence: Synthetic
      peptide"

<400> 55
Gly His Thr Phe Gly Thr Tyr Gly Met Ser 
1               5                   10  


<210> 56
<211> 10
<212> PRT
<213> Artificial Sequence

<220>
<221> source
<223> /note="Description of Artificial Sequence: Synthetic
      peptide"

<400> 56
Gly His Thr Arg Thr Thr Tyr Gly Met Ser 
1               5                   10  


<210> 57
<211> 10
<212> PRT
<213> Artificial Sequence

<220>
<221> source
<223> /note="Description of Artificial Sequence: Synthetic
      peptide"

<400> 57
Gly His Thr Ser Thr Thr Tyr Gly Met Ser 
1               5                   10  


<210> 58
<211> 18
<212> PRT
<213> Artificial Sequence

<220>
<221> source
<223> /note="Description of Artificial Sequence: Synthetic
      peptide"

<400> 58
Gly Trp Ile Asn Trp His Ser Gly Val Pro Thr Tyr Ala Asp Asp Phe 
1               5                   10                  15      


Lys Gly 
        


<210> 59
<211> 18
<212> PRT
<213> Artificial Sequence

<220>
<221> source
<223> /note="Description of Artificial Sequence: Synthetic
      peptide"

<400> 59
Gly Trp Ile Asn Met His Ser Gly Val Pro Thr Tyr Ala Asp Asp Phe 
1               5                   10                  15      


Lys Gly 
        


<210> 60
<211> 18
<212> PRT
<213> Artificial Sequence

<220>
<221> source
<223> /note="Description of Artificial Sequence: Synthetic
      peptide"

<400> 60
Gly Trp Ile Asn Thr His Ser Gly Val Pro Thr Met Ala Asp Asp Phe 
1               5                   10                  15      


Lys Gly 
        


<210> 61
<211> 18
<212> PRT
<213> Artificial Sequence

<220>
<221> source
<223> /note="Description of Artificial Sequence: Synthetic
      peptide"

<400> 61
Gly Trp Ile Asn Thr His Ser Gly Val Pro Thr Tyr Ala His Asp Phe 
1               5                   10                  15      


Lys Gly 
        


<210> 62
<211> 18
<212> PRT
<213> Artificial Sequence

<220>
<221> source
<223> /note="Description of Artificial Sequence: Synthetic
      peptide"


<220>
<221> MOD_RES
<222> (15)..(15)
<223> Any amino acid

<400> 62
Gly Trp Ile Asn Thr His Ser Gly Val Pro Thr Tyr Ala Asp Xaa Phe 
1               5                   10                  15      


Lys Gly 
        


<210> 63
<211> 18
<212> PRT
<213> Artificial Sequence

<220>
<221> source
<223> /note="Description of Artificial Sequence: Synthetic
      peptide"

<400> 63
Gly Trp Ile Asn Ile His Ser Gly Val Pro Thr Tyr Ala Asp Asp Phe 
1               5                   10                  15      


Lys Gly 
        


<210> 64
<211> 18
<212> PRT
<213> Artificial Sequence

<220>
<221> source
<223> /note="Description of Artificial Sequence: Synthetic
      peptide"

<400> 64
Gly Trp Ile Asn Trp His Ser Gly Val Pro Thr Tyr Ala Asp Asp Phe 
1               5                   10                  15      


Lys Gly 
        


<210> 65
<211> 18
<212> PRT
<213> Artificial Sequence

<220>
<221> source
<223> /note="Description of Artificial Sequence: Synthetic
      peptide"

<400> 65
Gly Trp Ile Asn Thr Arg Ser Gly Val Pro Thr Tyr Ala Asp Asp Phe 
1               5                   10                  15      


Lys Gly 
        


<210> 66
<211> 18
<212> PRT
<213> Artificial Sequence

<220>
<221> source
<223> /note="Description of Artificial Sequence: Synthetic
      peptide"

<400> 66
Gly Trp Ile Asn Thr His Ser Gly Val Pro Thr Ile Ala Asp Asp Phe 
1               5                   10                  15      


Lys Gly 
        


<210> 67
<211> 18
<212> PRT
<213> Artificial Sequence

<220>
<221> source
<223> /note="Description of Artificial Sequence: Synthetic
      peptide"

<400> 67
Gly Trp Ile Asn Thr His Ser Gly Val Pro Thr Tyr Ala Asp Asp Phe 
1               5                   10                  15      


Ser Gly 
        


<210> 68
<211> 18
<212> PRT
<213> Artificial Sequence

<220>
<221> source
<223> /note="Description of Artificial Sequence: Synthetic
      peptide"

<400> 68
Gly Trp Ile Asn Thr His Ser Gly Val Pro Thr Thr Ala Asp Asp Phe 
1               5                   10                  15      


Lys Gly 
        


<210> 69
<211> 18
<212> PRT
<213> Artificial Sequence

<220>
<221> source
<223> /note="Description of Artificial Sequence: Synthetic
      peptide"

<400> 69
Gly Trp Ile Asn Thr His Ser Gly Val Pro Thr Tyr Ala Asp Thr Phe 
1               5                   10                  15      


Lys Gly 
        


<210> 70
<211> 18
<212> PRT
<213> Artificial Sequence

<220>
<221> source
<223> /note="Description of Artificial Sequence: Synthetic
      peptide"

<400> 70
Gly Trp Ile Asn Ile His Ser Gly Val Pro Thr Tyr Ala Asp Asp Phe 
1               5                   10                  15      


Lys Gly 
        


<210> 71
<211> 18
<212> PRT
<213> Artificial Sequence

<220>
<221> source
<223> /note="Description of Artificial Sequence: Synthetic
      peptide"

<400> 71
Gly Trp Ile Asn Thr His Ser Gly Val Pro Thr Tyr Ala Asp Met Phe 
1               5                   10                  15      


Lys Gly 
        


<210> 72
<211> 18
<212> PRT
<213> Artificial Sequence

<220>
<221> source
<223> /note="Description of Artificial Sequence: Synthetic
      peptide"

<400> 72
Gly Trp Ile Asn Thr His Ser Gly Val Pro Thr Tyr Ala Asp Asp Tyr 
1               5                   10                  15      


Lys Gly 
        


<210> 73
<211> 18
<212> PRT
<213> Artificial Sequence

<220>
<221> source
<223> /note="Description of Artificial Sequence: Synthetic
      peptide"

<400> 73
Gly Trp Ile Asn Thr His Ser Gly Val Pro Thr Tyr Ala Asp Asp Phe 
1               5                   10                  15      


Lys Arg 
        


<210> 74
<211> 10
<212> PRT
<213> Artificial Sequence

<220>
<221> source
<223> /note="Description of Artificial Sequence: Synthetic
      peptide"

<400> 74
Ala Asn Leu Gly Ser Ser Ala Val Asp Tyr 
1               5                   10  


<210> 75
<211> 10
<212> PRT
<213> Artificial Sequence

<220>
<221> source
<223> /note="Description of Artificial Sequence: Synthetic
      peptide"

<400> 75
Ala Arg Leu Gly Ser Cys Ala Val Asp Tyr 
1               5                   10  


<210> 76
<211> 10
<212> PRT
<213> Artificial Sequence

<220>
<221> source
<223> /note="Description of Artificial Sequence: Synthetic
      peptide"

<400> 76
Ala Arg Leu Gly Ser Tyr Ala Val Asp Tyr 
1               5                   10  


<210> 77
<211> 10
<212> PRT
<213> Artificial Sequence

<220>
<221> source
<223> /note="Description of Artificial Sequence: Synthetic
      peptide"

<400> 77
Ala Arg Leu Gly Ser Ser Ala Val Asp Ala 
1               5                   10  


<210> 78
<211> 112
<212> PRT
<213> Artificial Sequence

<220>
<221> source
<223> /note="Description of Artificial Sequence: Synthetic
      polypeptide"

<400> 78
Asp Ile Gln Leu Thr Gln Ser Pro Ser Ser Leu Ser Ala Ser Val Gly 
1               5                   10                  15      


Asp Arg Val Thr Ile Thr Cys Lys Ala Ser Gln Ser Val Asp Tyr Ser 
            20                  25                  30          


Gly Asp Ser Tyr Met Ser Trp Tyr Gln Gln Lys Pro Gly Lys Ala Pro 
        35                  40                  45              


Lys Leu Leu Ile Tyr Gly Ala Ser Asn Leu Glu Ser Gly Val Pro Ser 
    50                  55                  60                  


Arg Phe Ser Gly Ser Gly Ser Gly Thr Asp Phe Thr Leu Thr Ile Ser 
65                  70                  75                  80  


Ser Leu Gln Pro Glu Asp Phe Ala Thr Tyr Tyr Cys Gln Gln Asn Asn 
                85                  90                  95      


Glu Glu Pro Tyr Thr Phe Gly Gln Gly Thr Lys Val Glu Ile Lys Arg 
            100                 105                 110         


<210> 79
<211> 112
<212> PRT
<213> Artificial Sequence

<220>
<221> source
<223> /note="Description of Artificial Sequence: Synthetic
      polypeptide"

<400> 79
Asp Ile Gln Leu Thr Gln Ser Pro Ser Ser Leu Ser Ala Ser Val Gly 
1               5                   10                  15      


Asp Arg Val Thr Ile Thr Cys Lys Ala Ser Gln Ser Val Asp Tyr Ser 
            20                  25                  30          


Gly Asp Ser Tyr Met Ser Trp Tyr Gln Gln Lys Pro Gly Lys Ala Pro 
        35                  40                  45              


Lys Leu Leu Ile Tyr Gly Ala Ser Asn Leu Glu Ser Gly Val Pro Ser 
    50                  55                  60                  


Arg Phe Ser Gly Ser Gly Ser Gly Thr Asp Phe Thr Leu Thr Ile Ser 
65                  70                  75                  80  


Ser Leu Gln Pro Glu Asp Phe Ala Thr Tyr Tyr Cys Gln Gln Asn Asn 
                85                  90                  95      


Glu Glu Pro Tyr Thr Phe Gly Gln Gly Thr Lys Val Glu Ile Lys Arg 
            100                 105                 110         


<210> 80
<211> 117
<212> PRT
<213> Artificial Sequence

<220>
<221> source
<223> /note="Description of Artificial Sequence: Synthetic
      polypeptide"

<400> 80
Glu Val Gln Leu Val Glu Ser Gly Gly Gly Leu Val Gln Pro Gly Gly 
1               5                   10                  15      


Ser Leu Arg Leu Ser Cys Ala Ala Ser Gly His Thr Phe Thr Thr Tyr 
            20                  25                  30          


Gly Met Ser Trp Val Arg Gln Ala Pro Gly Lys Gly Leu Glu Trp Val 
        35                  40                  45              


Gly Trp Ile Asn Thr His Ser Gly Val Pro Thr Tyr Ala Asp Asp Phe 
    50                  55                  60                  


Lys Gly Arg Phe Thr Ile Ser Leu Asp Asn Ser Lys Asn Thr Ala Tyr 
65                  70                  75                  80  


Leu Gln Met Asn Ser Leu Arg Ala Glu Asp Thr Ala Val Tyr Tyr Cys 
                85                  90                  95      


Ala Arg Leu Gly Ser Ser Ala Val Asp Tyr Trp Gly Gln Gly Thr Leu 
            100                 105                 110         


Val Thr Val Ser Ser 
        115         


<210> 81
<211> 117
<212> PRT
<213> Artificial Sequence

<220>
<221> source
<223> /note="Description of Artificial Sequence: Synthetic
      polypeptide"

<400> 81
Glu Val Gln Leu Val Glu Ser Gly Gly Gly Leu Val Gln Pro Gly Gly 
1               5                   10                  15      


Ser Leu Arg Leu Ser Cys Ala Ala Ser Gly His Thr Phe Thr Thr Tyr 
            20                  25                  30          


Gly Met Ser Trp Val Arg Gln Ala Pro Gly Lys Gly Leu Glu Trp Val 
        35                  40                  45              


Gly Trp Ile Asn Thr His Ser Gly Val Pro Thr Tyr Ala Asp Asp Phe 
    50                  55                  60                  


Lys Gly Arg Phe Thr Ile Ser Leu Asp Asn Ser Lys Ser Thr Ala Tyr 
65                  70                  75                  80  


Leu Gln Met Asn Ser Leu Arg Ala Glu Asp Thr Ala Val Tyr Phe Cys 
                85                  90                  95      


Ala Arg Leu Gly Ser Ser Ala Val Asp Tyr Trp Gly Gln Gly Thr Leu 
            100                 105                 110         


Val Thr Val Ser Ser 
        115         


<210> 82
<211> 112
<212> PRT
<213> Artificial Sequence

<220>
<221> source
<223> /note="Description of Artificial Sequence: Synthetic
      polypeptide"

<400> 82
Asp Ile Gln Met Thr Gln Ser Pro Ser Ser Leu Ser Ala Ser Val Gly 
1               5                   10                  15      


Asp Arg Val Thr Ile Thr Cys Lys Ala Ser Gln Ser Val Asp Tyr Ser 
            20                  25                  30          


Gly Asp Ser Tyr Met Ser Trp Tyr Gln Gln Lys Pro Gly Lys Ala Pro 
        35                  40                  45              


Lys Leu Leu Ile Tyr Gly Ala Ser Tyr Arg Glu Ser Gly Val Pro Ser 
    50                  55                  60                  


Arg Phe Ser Gly Ser Gly Ser Gly Thr Asp Phe Thr Leu Thr Ile Ser 
65                  70                  75                  80  


Ser Leu Gln Pro Glu Asp Phe Ala Thr Tyr Tyr Cys Gln Gln Asn Asn 
                85                  90                  95      


Glu Glu Pro Tyr Thr Phe Gly Gln Gly Thr Lys Val Glu Ile Lys Arg 
            100                 105                 110         


<210> 83
<211> 112
<212> PRT
<213> Artificial Sequence

<220>
<221> source
<223> /note="Description of Artificial Sequence: Synthetic
      polypeptide"

<400> 83
Asp Ile Gln Met Thr Gln Ser Pro Ser Ser Leu Ser Ala Ser Val Gly 
1               5                   10                  15      


Asp Arg Val Thr Ile Thr Cys Lys Ala Ser Gln Ser Val Asp Tyr Ser 
            20                  25                  30          


Gly Asp Ser Tyr Met Ser Trp Tyr Gln Gln Lys Pro Gly Lys Ala Pro 
        35                  40                  45              


Lys Leu Leu Ile Tyr Gly Ala Ser Tyr Arg Glu Ser Gly Val Pro Ser 
    50                  55                  60                  


Arg Phe Ser Gly Ser Gly Ser Gly Thr Asp Phe Thr Leu Thr Ile Ser 
65                  70                  75                  80  


Ser Leu Gln Pro Glu Asp Phe Ala Thr Tyr Tyr Cys Gln Gln Asn Asn 
                85                  90                  95      


Glu Glu Pro Tyr Thr Phe Gly Gln Gly Thr Lys Val Glu Ile Lys Arg 
            100                 105                 110         


<210> 84
<211> 117
<212> PRT
<213> Artificial Sequence

<220>
<221> source
<223> /note="Description of Artificial Sequence: Synthetic
      polypeptide"

<400> 84
Glu Val Gln Leu Val Glu Ser Gly Gly Gly Leu Val Gln Pro Gly Gly 
1               5                   10                  15      


Ser Leu Arg Leu Ser Cys Ala Ala Ser Gly His Thr Phe Thr Thr Tyr 
            20                  25                  30          


Gly Met Ser Trp Val Arg Gln Ala Pro Gly Lys Gly Leu Glu Trp Val 
        35                  40                  45              


Gly Trp Ile Asn Thr His Ser Gly Val Pro Thr Tyr Ala Asp Asp Phe 
    50                  55                  60                  


Lys Gly Arg Phe Thr Ile Ser Leu Asp Asn Ser Lys Asn Thr Ala Tyr 
65                  70                  75                  80  


Leu Gln Met Asn Ser Leu Arg Ala Glu Asp Thr Ala Val Tyr Tyr Cys 
                85                  90                  95      


Ala Arg Leu Gly Ser Tyr Ala Val Asp Tyr Trp Gly Gln Gly Thr Leu 
            100                 105                 110         


Val Thr Val Ser Ser 
        115         


<210> 85
<211> 117
<212> PRT
<213> Artificial Sequence

<220>
<221> source
<223> /note="Description of Artificial Sequence: Synthetic
      polypeptide"

<400> 85
Glu Ile Gln Leu Val Glu Ser Gly Gly Gly Leu Val Gln Pro Gly Gly 
1               5                   10                  15      


Ser Leu Arg Leu Ser Cys Ala Ala Ser Gly His Thr Phe Thr Thr Tyr 
            20                  25                  30          


Gly Met Ser Trp Val Arg Gln Ala Pro Gly Lys Gly Leu Glu Trp Met 
        35                  40                  45              


Gly Trp Ile Asn Thr His Ser Gly Val Pro Thr Tyr Ala Asp Asp Phe 
    50                  55                  60                  


Lys Gly Arg Phe Thr Ile Ser Leu Asp Asn Ser Lys Ser Thr Ala Tyr 
65                  70                  75                  80  


Leu Gln Met Asn Ser Leu Arg Ala Glu Asp Thr Ala Val Tyr Phe Cys 
                85                  90                  95      


Ala Arg Leu Gly Ser Tyr Ala Val Asp Tyr Trp Gly Gln Gly Thr Leu 
            100                 105                 110         


Val Thr Val Ser Ser 
        115         


<210> 86
<211> 113
<212> PRT
<213> Artificial Sequence

<220>
<221> source
<223> /note="Description of Artificial Sequence: Synthetic
      polypeptide"

<400> 86
Asp Ile Gln Met Thr Gln Ser Pro Ser Ser Leu Ser Ala Ser Val Gly 
1               5                   10                  15      


Asp Arg Val Thr Ile Thr Cys Arg Thr Ser Gln Ser Leu Val His Ile 
            20                  25                  30          


Asn Gly Ile Thr Tyr Leu His Trp Tyr Gln Gln Lys Pro Gly Lys Ala 
        35                  40                  45              


Pro Lys Leu Leu Ile Tyr Arg Val Ser Asn Arg Phe Ser Gly Val Pro 
    50                  55                  60                  


Ser Arg Phe Ser Gly Ser Gly Ser Gly Thr Asp Phe Thr Leu Thr Ile 
65                  70                  75                  80  


Ser Ser Leu Gln Pro Glu Asp Phe Ala Thr Tyr Tyr Cys Ser Gln Ser 
                85                  90                  95      


Thr His Val Pro Leu Thr Phe Gly Gln Gly Thr Lys Val Glu Ile Lys 
            100                 105                 110         


Arg 
    


<210> 87
<211> 123
<212> PRT
<213> Artificial Sequence

<220>
<221> source
<223> /note="Description of Artificial Sequence: Synthetic
      polypeptide"

<400> 87
Glu Val Gln Leu Val Glu Ser Gly Gly Gly Leu Val Gln Pro Gly Gly 
1               5                   10                  15      


Ser Leu Arg Leu Ser Cys Ala Ala Ser Gly Tyr Thr Phe Ile Asp Tyr 
            20                  25                  30          


Tyr Met Asn Trp Val Arg Gln Ala Pro Gly Lys Gly Leu Glu Trp Val 
        35                  40                  45              


Gly Asp Ile Asn Leu Asp Asn Gly Gly Thr His Tyr Asn Gln Lys Phe 
    50                  55                  60                  


Lys Gly Arg Phe Thr Ile Ser Arg Asp Asn Ser Lys Asn Thr Leu Tyr 
65                  70                  75                  80  


Leu Gln Met Asn Ser Leu Arg Ala Glu Asp Thr Ala Val Tyr Tyr Cys 
                85                  90                  95      


Ala Arg Glu Gly Val Tyr His Asp Tyr Asp Asp Tyr Ala Met Asp Tyr 
            100                 105                 110         


Trp Gly Gln Gly Thr Leu Val Thr Val Ser Ser 
        115                 120             


<210> 88
<211> 13
<212> PRT
<213> Artificial Sequence

<220>
<221> source
<223> /note="Description of Artificial Sequence: Synthetic
      peptide"

<400> 88
Glu Asp Phe Ala Thr Tyr Tyr Cys Ser Gln Ser Thr His 
1               5                   10              


<210> 89
<211> 13
<212> PRT
<213> Artificial Sequence

<220>
<221> source
<223> /note="Description of Artificial Sequence: Synthetic
      peptide"

<400> 89
Glu Asp Leu Gly Val Tyr Phe Cys Ser Gln Ser Thr His 
1               5                   10              


<210> 90
<211> 39
<212> DNA
<213> Artificial Sequence

<220>
<221> source
<223> /note="Description of Artificial Sequence: Synthetic
      oligonucleotide"

<400> 90
gaagacttcg caacttatta ctgtagccag agcacccac                              39


<210> 91
<211> 39
<212> DNA
<213> Artificial Sequence

<220>
<221> source
<223> /note="Description of Artificial Sequence: Synthetic
      oligonucleotide"

<400> 91
gaagacttcg caacttattw ctgtagccag agcacccac                              39


<210> 92
<211> 13
<212> PRT
<213> Artificial Sequence

<220>
<221> source
<223> /note="Description of Artificial Sequence: Synthetic
      peptide"

<400> 92
Gly Lys Gly Leu Glu Trp Val Gly Asp Ile Asn Leu Asp 
1               5                   10              


<210> 93
<211> 13
<212> PRT
<213> Artificial Sequence

<220>
<221> source
<223> /note="Description of Artificial Sequence: Synthetic
      peptide"

<400> 93
Gly Lys Ser Leu Glu Trp Ile Gly Asp Ile Asn Leu Asp 
1               5                   10              


<210> 94
<211> 39
<212> DNA
<213> Artificial Sequence

<220>
<221> source
<223> /note="Description of Artificial Sequence: Synthetic
      oligonucleotide"

<400> 94
ggtaagggcc tggaatgggt tggtgatatc aacctggat                              39


<210> 95
<211> 39
<212> DNA
<213> Artificial Sequence

<220>
<221> source
<223> /note="Description of Artificial Sequence: Synthetic
      oligonucleotide"

<400> 95
ggtaagggcc tggaatggrt cggtgatatc aacctggat                              39


<210> 96
<211> 26
<212> PRT
<213> Artificial Sequence

<220>
<221> source
<223> /note="Description of Artificial Sequence: Synthetic
      peptide"

<400> 96
Gln Lys Phe Lys Gly Arg Phe Thr Ile Ser Arg Asp Thr Ser Lys Asn 
1               5                   10                  15      


Thr Leu Tyr Leu Gln Met Asn Ser Leu Arg 
            20                  25      


<210> 97
<211> 26
<212> PRT
<213> Artificial Sequence

<220>
<221> source
<223> /note="Description of Artificial Sequence: Synthetic
      peptide"

<400> 97
Gln Lys Phe Lys Gly Lys Ala Thr Leu Thr Val Asp Lys Ser Ser Ser 
1               5                   10                  15      


Thr Ala Tyr Met Glu Leu His Ser Leu Thr 
            20                  25      


<210> 98
<211> 78
<212> DNA
<213> Artificial Sequence

<220>
<221> source
<223> /note="Description of Artificial Sequence: Synthetic
      oligonucleotide"

<400> 98
cagaaattca aaggtcgttt cactataagc cgcgacacct ccaaaaacac actgtaccta       60

caaatgaaca gcttaaga                                                     78


<210> 99
<211> 78
<212> DNA
<213> Artificial Sequence

<220>
<221> source
<223> /note="Description of Artificial Sequence: Synthetic
      oligonucleotide"

<400> 99
cagaaattca aaggtcgtky cactmtcagc sktgacamgt ccarsarcac asygtacmtg       60

caaatgaaca gcttaaga                                                     78


<210> 100
<211> 16
<212> PRT
<213> Artificial Sequence

<220>
<221> source
<223> /note="Description of Artificial Sequence: Synthetic
      peptide"

<400> 100
Arg Thr Ser Gln Ser Leu Val His Ile Asn Gly Ile Thr Tyr Leu His 
1               5                   10                  15      


<210> 101
<211> 7
<212> PRT
<213> Artificial Sequence

<220>
<221> source
<223> /note="Description of Artificial Sequence: Synthetic
      peptide"

<400> 101
Arg Val Ser Asn Arg Phe Ser 
1               5           


<210> 102
<211> 9
<212> PRT
<213> Artificial Sequence

<220>
<221> source
<223> /note="Description of Artificial Sequence: Synthetic
      peptide"

<400> 102
Ser Gln Ser Thr His Val Pro Leu Thr 
1               5                   


<210> 103
<211> 10
<212> PRT
<213> Artificial Sequence

<220>
<221> source
<223> /note="Description of Artificial Sequence: Synthetic
      peptide"

<400> 103
Gly Tyr Thr Phe Ile Asp Tyr Tyr Met Asn 
1               5                   10  


<210> 104
<211> 18
<212> PRT
<213> Artificial Sequence

<220>
<221> source
<223> /note="Description of Artificial Sequence: Synthetic
      peptide"

<400> 104
Gly Asp Ile Asn Leu Asp Asn Gly Gly Thr His Tyr Asn Gln Lys Phe 
1               5                   10                  15      


Lys Gly 
        


<210> 105
<211> 16
<212> PRT
<213> Artificial Sequence

<220>
<221> source
<223> /note="Description of Artificial Sequence: Synthetic
      peptide"

<400> 105
Ala Arg Glu Gly Val Tyr His Asp Tyr Asp Asp Tyr Ala Met Asp Tyr 
1               5                   10                  15      


<210> 106
<211> 16
<212> PRT
<213> Artificial Sequence

<220>
<221> source
<223> /note="Description of Artificial Sequence: Synthetic
      peptide"

<400> 106
Gln Thr Ser Gln Ser Leu Val His Ile Asn Gly Ile Thr Tyr Leu His 
1               5                   10                  15      


<210> 107
<211> 16
<212> PRT
<213> Artificial Sequence

<220>
<221> source
<223> /note="Description of Artificial Sequence: Synthetic
      peptide"

<400> 107
Arg Thr Ser Gln Ser Leu Val His Tyr Asn Gly Ile Thr Tyr Leu His 
1               5                   10                  15      


<210> 108
<211> 16
<212> PRT
<213> Artificial Sequence

<220>
<221> source
<223> /note="Description of Artificial Sequence: Synthetic
      peptide"

<400> 108
Arg Thr Ser Gln Ser Leu Val Pro Ile Asn Gly Ile Thr Tyr Leu His 
1               5                   10                  15      


<210> 109
<211> 16
<212> PRT
<213> Artificial Sequence

<220>
<221> source
<223> /note="Description of Artificial Sequence: Synthetic
      peptide"

<400> 109
Ser Thr Ser Gln Ser Leu Val His Ile Asn Gly Ile Thr Tyr Leu His 
1               5                   10                  15      


<210> 110
<211> 16
<212> PRT
<213> Artificial Sequence

<220>
<221> source
<223> /note="Description of Artificial Sequence: Synthetic
      peptide"

<400> 110
Arg Thr Ser Gln Ser Leu Val His Leu Asn Gly Ile Thr Tyr Leu His 
1               5                   10                  15      


<210> 111
<211> 16
<212> PRT
<213> Artificial Sequence

<220>
<221> source
<223> /note="Description of Artificial Sequence: Synthetic
      peptide"

<400> 111
Leu Thr Ser Gln Ser Leu Val His Ile Asn Gly Ile Thr Tyr Leu His 
1               5                   10                  15      


<210> 112
<211> 16
<212> PRT
<213> Artificial Sequence

<220>
<221> source
<223> /note="Description of Artificial Sequence: Synthetic
      peptide"

<400> 112
Arg Trp Ser Gln Ser Leu Val His Ile Asn Gly Ile Thr Tyr Leu His 
1               5                   10                  15      


<210> 113
<211> 16
<212> PRT
<213> Artificial Sequence

<220>
<221> source
<223> /note="Description of Artificial Sequence: Synthetic
      peptide"

<400> 113
Arg Pro Ser Gln Ser Leu Val His Ile Asn Gly Ile Thr Tyr Leu His 
1               5                   10                  15      


<210> 114
<211> 16
<212> PRT
<213> Artificial Sequence

<220>
<221> source
<223> /note="Description of Artificial Sequence: Synthetic
      peptide"

<400> 114
Arg Thr His Gln Ser Leu Val His Ile Asn Gly Ile Thr Tyr Leu His 
1               5                   10                  15      


<210> 115
<211> 16
<212> PRT
<213> Artificial Sequence

<220>
<221> source
<223> /note="Description of Artificial Sequence: Synthetic
      peptide"

<400> 115
Arg Thr Ser Gln Ser Val Val His Ile Asn Gly Ile Thr Tyr Leu His 
1               5                   10                  15      


<210> 116
<211> 16
<212> PRT
<213> Artificial Sequence

<220>
<221> source
<223> /note="Description of Artificial Sequence: Synthetic
      peptide"

<400> 116
Arg Thr Ser Gln Ser Leu Val His Thr Asn Gly Ile Thr Tyr Leu His 
1               5                   10                  15      


<210> 117
<211> 16
<212> PRT
<213> Artificial Sequence

<220>
<221> source
<223> /note="Description of Artificial Sequence: Synthetic
      peptide"

<400> 117
Arg Thr Ser Gln Ser Leu Val His Leu Asn Gly Ile Thr Tyr Leu His 
1               5                   10                  15      


<210> 118
<211> 16
<212> PRT
<213> Artificial Sequence

<220>
<221> source
<223> /note="Description of Artificial Sequence: Synthetic
      peptide"

<400> 118
Arg Thr Ser Gln Ser Leu Val His Pro Asn Gly Ile Thr Tyr Leu His 
1               5                   10                  15      


<210> 119
<211> 16
<212> PRT
<213> Artificial Sequence

<220>
<221> source
<223> /note="Description of Artificial Sequence: Synthetic
      peptide"

<400> 119
Arg Thr Ser Gln Ser Leu Val His Ile Asn Gly Ile Thr Tyr Leu Gly 
1               5                   10                  15      


<210> 120
<211> 16
<212> PRT
<213> Artificial Sequence

<220>
<221> source
<223> /note="Description of Artificial Sequence: Synthetic
      peptide"

<400> 120
Thr Thr Ser Gln Ser Leu Val His Ile Asn Gly Ile Thr Tyr Leu His 
1               5                   10                  15      


<210> 121
<211> 16
<212> PRT
<213> Artificial Sequence

<220>
<221> source
<223> /note="Description of Artificial Sequence: Synthetic
      peptide"

<400> 121
Leu Thr Ser Gln Ser Leu Val His Ile Asn Gly Ile Thr Tyr Leu His 
1               5                   10                  15      


<210> 122
<211> 16
<212> PRT
<213> Artificial Sequence

<220>
<221> source
<223> /note="Description of Artificial Sequence: Synthetic
      peptide"

<400> 122
Arg Thr Ser Asp Ser Leu Val His Ile Asn Gly Ile Thr Tyr Leu His 
1               5                   10                  15      


<210> 123
<211> 16
<212> PRT
<213> Artificial Sequence

<220>
<221> source
<223> /note="Description of Artificial Sequence: Synthetic
      peptide"

<400> 123
Arg Thr Ser Gln Gly Leu Val His Ile Asn Gly Ile Thr Tyr Leu His 
1               5                   10                  15      


<210> 124
<211> 16
<212> PRT
<213> Artificial Sequence

<220>
<221> source
<223> /note="Description of Artificial Sequence: Synthetic
      peptide"

<400> 124
Arg Thr Ser Gln Ser Leu Val His Tyr Asn Gly Ile Thr Tyr Leu His 
1               5                   10                  15      


<210> 125
<211> 7
<212> PRT
<213> Artificial Sequence

<220>
<221> source
<223> /note="Description of Artificial Sequence: Synthetic
      peptide"

<400> 125
Arg Val Ser Asn Asp Phe Ser 
1               5           


<210> 126
<211> 7
<212> PRT
<213> Artificial Sequence

<220>
<221> source
<223> /note="Description of Artificial Sequence: Synthetic
      peptide"

<400> 126
Arg Val Ser Asn Arg Ile Ser 
1               5           


<210> 127
<211> 7
<212> PRT
<213> Artificial Sequence

<220>
<221> source
<223> /note="Description of Artificial Sequence: Synthetic
      peptide"

<400> 127
Arg Val Ser Asn Arg Thr Ser 
1               5           


<210> 128
<211> 7
<212> PRT
<213> Artificial Sequence

<220>
<221> source
<223> /note="Description of Artificial Sequence: Synthetic
      peptide"

<400> 128
Arg Val Ser Asn Arg Gly Ser 
1               5           


<210> 129
<211> 7
<212> PRT
<213> Artificial Sequence

<220>
<221> source
<223> /note="Description of Artificial Sequence: Synthetic
      peptide"

<400> 129
Arg Val Ser Asn Arg Ala Ser 
1               5           


<210> 130
<211> 9
<212> PRT
<213> Artificial Sequence

<220>
<221> source
<223> /note="Description of Artificial Sequence: Synthetic
      peptide"

<400> 130
Ala Gln Ser Thr His Val Pro Leu Thr 
1               5                   


<210> 131
<211> 9
<212> PRT
<213> Artificial Sequence

<220>
<221> source
<223> /note="Description of Artificial Sequence: Synthetic
      peptide"

<400> 131
Gly Gln Ser Thr His Val Pro Leu Thr 
1               5                   


<210> 132
<211> 9
<212> PRT
<213> Artificial Sequence

<220>
<221> source
<223> /note="Description of Artificial Sequence: Synthetic
      peptide"

<400> 132
Leu Gln Ser Thr His Val Pro Leu Thr 
1               5                   


<210> 133
<211> 9
<212> PRT
<213> Artificial Sequence

<220>
<221> source
<223> /note="Description of Artificial Sequence: Synthetic
      peptide"

<400> 133
Ser Gln Ser Cys His Val Pro Leu Thr 
1               5                   


<210> 134
<211> 9
<212> PRT
<213> Artificial Sequence

<220>
<221> source
<223> /note="Description of Artificial Sequence: Synthetic
      peptide"

<400> 134
Ser Gln Ser Thr Phe Val Pro Leu Thr 
1               5                   


<210> 135
<211> 9
<212> PRT
<213> Artificial Sequence

<220>
<221> source
<223> /note="Description of Artificial Sequence: Synthetic
      peptide"

<400> 135
Ala Gln Ser Thr His Val Pro Leu Thr 
1               5                   


<210> 136
<211> 9
<212> PRT
<213> Artificial Sequence

<220>
<221> source
<223> /note="Description of Artificial Sequence: Synthetic
      peptide"

<400> 136
Gly Gln Ser Thr His Val Pro Leu Thr 
1               5                   


<210> 137
<211> 9
<212> PRT
<213> Artificial Sequence

<220>
<221> source
<223> /note="Description of Artificial Sequence: Synthetic
      peptide"

<400> 137
Leu Gln Ser Thr His Val Pro Leu Thr 
1               5                   


<210> 138
<211> 9
<212> PRT
<213> Artificial Sequence

<220>
<221> source
<223> /note="Description of Artificial Sequence: Synthetic
      peptide"

<400> 138
Ala Gln Ser Thr His Val Pro Leu Thr 
1               5                   


<210> 139
<211> 9
<212> PRT
<213> Artificial Sequence

<220>
<221> source
<223> /note="Description of Artificial Sequence: Synthetic
      peptide"

<400> 139
Asn Gln Ser Thr His Val Pro Leu Thr 
1               5                   


<210> 140
<211> 9
<212> PRT
<213> Artificial Sequence

<220>
<221> source
<223> /note="Description of Artificial Sequence: Synthetic
      peptide"

<400> 140
Ala Gln Ser Thr His Val Pro Leu Thr 
1               5                   


<210> 141
<211> 9
<212> PRT
<213> Artificial Sequence

<220>
<221> source
<223> /note="Description of Artificial Sequence: Synthetic
      peptide"

<400> 141
Ile Gln Ser Thr His Val Pro Leu Thr 
1               5                   


<210> 142
<211> 9
<212> PRT
<213> Artificial Sequence

<220>
<221> source
<223> /note="Description of Artificial Sequence: Synthetic
      peptide"

<400> 142
Leu Gln Ser Thr His Val Pro Leu Thr 
1               5                   


<210> 143
<211> 9
<212> PRT
<213> Artificial Sequence

<220>
<221> source
<223> /note="Description of Artificial Sequence: Synthetic
      peptide"

<400> 143
Val Gln Ser Thr His Val Pro Leu Thr 
1               5                   


<210> 144
<211> 9
<212> PRT
<213> Artificial Sequence

<220>
<221> source
<223> /note="Description of Artificial Sequence: Synthetic
      peptide"

<400> 144
Thr Gln Ser Thr His Val Pro Leu Thr 
1               5                   


<210> 145
<211> 9
<212> PRT
<213> Artificial Sequence

<220>
<221> source
<223> /note="Description of Artificial Sequence: Synthetic
      peptide"

<400> 145
Lys Gln Ser Thr His Val Pro Leu Thr 
1               5                   


<210> 146
<211> 10
<212> PRT
<213> Artificial Sequence

<220>
<221> source
<223> /note="Description of Artificial Sequence: Synthetic
      peptide"

<400> 146
Gly Tyr Thr Val Ile Asp Tyr Tyr Met Asn 
1               5                   10  


<210> 147
<211> 10
<212> PRT
<213> Artificial Sequence

<220>
<221> source
<223> /note="Description of Artificial Sequence: Synthetic
      peptide"

<400> 147
Gly Tyr Thr Phe Ile Asp Tyr Tyr Ile Asn 
1               5                   10  


<210> 148
<211> 10
<212> PRT
<213> Artificial Sequence

<220>
<221> source
<223> /note="Description of Artificial Sequence: Synthetic
      peptide"

<400> 148
Gly Tyr Asn Phe Ile Asp Tyr Tyr Met Asn 
1               5                   10  


<210> 149
<211> 10
<212> PRT
<213> Artificial Sequence

<220>
<221> source
<223> /note="Description of Artificial Sequence: Synthetic
      peptide"

<400> 149
Gly Tyr Thr Phe Met Asp Tyr Tyr Met Asn 
1               5                   10  


<210> 150
<211> 10
<212> PRT
<213> Artificial Sequence

<220>
<221> source
<223> /note="Description of Artificial Sequence: Synthetic
      peptide"

<400> 150
Gly Tyr Thr Phe Arg Asp Tyr Tyr Met Asn 
1               5                   10  


<210> 151
<211> 10
<212> PRT
<213> Artificial Sequence

<220>
<221> source
<223> /note="Description of Artificial Sequence: Synthetic
      peptide"

<400> 151
Gly Tyr Thr Phe Ser Asp Tyr Tyr Met Asn 
1               5                   10  


<210> 152
<211> 10
<212> PRT
<213> Artificial Sequence

<220>
<221> source
<223> /note="Description of Artificial Sequence: Synthetic
      peptide"

<400> 152
Gly Tyr Thr Phe Ile Asp Gln Tyr Met Asn 
1               5                   10  


<210> 153
<211> 10
<212> PRT
<213> Artificial Sequence

<220>
<221> source
<223> /note="Description of Artificial Sequence: Synthetic
      peptide"

<400> 153
Gly Tyr Thr Phe Ile Asp Lys Tyr Met Asn 
1               5                   10  


<210> 154
<211> 18
<212> PRT
<213> Artificial Sequence

<220>
<221> source
<223> /note="Description of Artificial Sequence: Synthetic
      peptide"

<400> 154
Gly Asp Ile Asn Leu Asp Gly Gly Gly Thr His Tyr Asn Gln Lys Phe 
1               5                   10                  15      


Lys Gly 
        


<210> 155
<211> 18
<212> PRT
<213> Artificial Sequence

<220>
<221> source
<223> /note="Description of Artificial Sequence: Synthetic
      peptide"

<400> 155
Gly Asp Ile Asn Leu Asp Asn Gly Lys Thr His Tyr Asn Gln Lys Phe 
1               5                   10                  15      


Lys Gly 
        


<210> 156
<211> 18
<212> PRT
<213> Artificial Sequence

<220>
<221> source
<223> /note="Description of Artificial Sequence: Synthetic
      peptide"

<400> 156
Gly Asp Ile Asn Leu Leu Asn Gly Gly Thr His Tyr Asn Gln Lys Phe 
1               5                   10                  15      


Lys Gly 
        


<210> 157
<211> 18
<212> PRT
<213> Artificial Sequence

<220>
<221> source
<223> /note="Description of Artificial Sequence: Synthetic
      peptide"

<400> 157
Gly Asp Ile Asn Leu Asp Asn Gly Arg Thr His Tyr Asn Gln Lys Phe 
1               5                   10                  15      


Lys Gly 
        


<210> 158
<211> 18
<212> PRT
<213> Artificial Sequence

<220>
<221> source
<223> /note="Description of Artificial Sequence: Synthetic
      peptide"

<400> 158
Gly Asp Ile Asn Leu Asp Asn Gly Ile Thr His Tyr Asn Gln Lys Phe 
1               5                   10                  15      


Lys Gly 
        


<210> 159
<211> 18
<212> PRT
<213> Artificial Sequence

<220>
<221> source
<223> /note="Description of Artificial Sequence: Synthetic
      peptide"

<400> 159
Gly Asp Ile Asn Leu Asp Asn Gly Gly Gly His Tyr Asn Gln Lys Phe 
1               5                   10                  15      


Lys Gly 
        


<210> 160
<211> 18
<212> PRT
<213> Artificial Sequence

<220>
<221> source
<223> /note="Description of Artificial Sequence: Synthetic
      peptide"

<400> 160
Gly Asp Ile Asn Leu Asp Asn Gly Gly Thr His Tyr Ser Gln Lys Phe 
1               5                   10                  15      


Lys Gly 
        


<210> 161
<211> 18
<212> PRT
<213> Artificial Sequence

<220>
<221> source
<223> /note="Description of Artificial Sequence: Synthetic
      peptide"

<400> 161
Gly Asp Ile Asn Leu Asp Asn Gly Gly Thr His Tyr Asn Asn Lys Phe 
1               5                   10                  15      


Lys Gly 
        


<210> 162
<211> 18
<212> PRT
<213> Artificial Sequence

<220>
<221> source
<223> /note="Description of Artificial Sequence: Synthetic
      peptide"

<400> 162
Gly Asp Ile Asn Leu Asp Asn Gly Gly Thr His Tyr Asn Gln Lys Gln 
1               5                   10                  15      


Lys Gly 
        


<210> 163
<211> 18
<212> PRT
<213> Artificial Sequence

<220>
<221> source
<223> /note="Description of Artificial Sequence: Synthetic
      peptide"

<400> 163
Gly Asp Ile Asn Leu Asp Asn Gly Gly Thr His Tyr Asn Gln Lys Phe 
1               5                   10                  15      


Thr Gly 
        


<210> 164
<211> 18
<212> PRT
<213> Artificial Sequence

<220>
<221> source
<223> /note="Description of Artificial Sequence: Synthetic
      peptide"

<400> 164
Gly Asp Ile Asn Leu Asp Asn Gly Gly Thr His Tyr Asn Gln Lys Phe 
1               5                   10                  15      


Lys His 
        


<210> 165
<211> 18
<212> PRT
<213> Artificial Sequence

<220>
<221> source
<223> /note="Description of Artificial Sequence: Synthetic
      peptide"

<400> 165
Gly Asp Ile Asn Leu Asp Asn Gly Gly Thr His Tyr Asn Gln Lys Phe 
1               5                   10                  15      


Lys Ser 
        


<210> 166
<211> 18
<212> PRT
<213> Artificial Sequence

<220>
<221> source
<223> /note="Description of Artificial Sequence: Synthetic
      peptide"

<400> 166
Gly Asp Ile Asn Ala Asp Asn Gly Gly Thr His Tyr Asn Gln Lys Phe 
1               5                   10                  15      


Lys Gly 
        


<210> 167
<211> 18
<212> PRT
<213> Artificial Sequence

<220>
<221> source
<223> /note="Description of Artificial Sequence: Synthetic
      peptide"

<400> 167
Gly Asp Ile Asn Leu Asp Asn Gly Thr Thr His Tyr Asn Gln Lys Phe 
1               5                   10                  15      


Lys Gly 
        


<210> 168
<211> 18
<212> PRT
<213> Artificial Sequence

<220>
<221> source
<223> /note="Description of Artificial Sequence: Synthetic
      peptide"

<400> 168
Gly Asp Ile Asn Leu Asp Asn Gly Gly Thr His Tyr Asn Ala Lys Phe 
1               5                   10                  15      


Lys Gly 
        


<210> 169
<211> 18
<212> PRT
<213> Artificial Sequence

<220>
<221> source
<223> /note="Description of Artificial Sequence: Synthetic
      peptide"

<400> 169
Gly Asp Ile Asn Leu Asp Asn Gly Gly Thr His Tyr Asn Asn Lys Phe 
1               5                   10                  15      


Lys Gly 
        


<210> 170
<211> 18
<212> PRT
<213> Artificial Sequence

<220>
<221> source
<223> /note="Description of Artificial Sequence: Synthetic
      peptide"

<400> 170
Gly Asp Ile Asn Leu Asp Asn Gly Gly Thr His Tyr Asn Gln Val Phe 
1               5                   10                  15      


Lys Gly 
        


<210> 171
<211> 18
<212> PRT
<213> Artificial Sequence

<220>
<221> source
<223> /note="Description of Artificial Sequence: Synthetic
      peptide"

<400> 171
Gly Asp Ile Asn Leu Asp Asn Gly Gly Thr His Tyr Asn Gln Lys Phe 
1               5                   10                  15      


Lys Arg 
        


<210> 172
<211> 18
<212> PRT
<213> Artificial Sequence

<220>
<221> source
<223> /note="Description of Artificial Sequence: Synthetic
      peptide"

<400> 172
Gly Asp Ile Asn Leu Asp Arg Gly Gly Thr His Tyr Asn Gln Lys Phe 
1               5                   10                  15      


Lys Gly 
        


<210> 173
<211> 18
<212> PRT
<213> Artificial Sequence

<220>
<221> source
<223> /note="Description of Artificial Sequence: Synthetic
      peptide"

<400> 173
Gly Asp Ile Asn Asn Asp Asn Gly Gly Thr His Tyr Asn Gln Lys Phe 
1               5                   10                  15      


Lys Gly 
        


<210> 174
<211> 18
<212> PRT
<213> Artificial Sequence

<220>
<221> source
<223> /note="Description of Artificial Sequence: Synthetic
      peptide"

<400> 174
Gly Asp Ile Asn Pro Asp Asn Gly Gly Thr His Tyr Asn Gln Lys Phe 
1               5                   10                  15      


Lys Gly 
        


<210> 175
<211> 18
<212> PRT
<213> Artificial Sequence

<220>
<221> source
<223> /note="Description of Artificial Sequence: Synthetic
      peptide"

<400> 175
Gly Asp Ile Asn Leu Arg Asn Gly Gly Thr His Tyr Asn Gln Lys Phe 
1               5                   10                  15      


Lys Gly 
        


<210> 176
<211> 18
<212> PRT
<213> Artificial Sequence

<220>
<221> source
<223> /note="Description of Artificial Sequence: Synthetic
      peptide"

<400> 176
Gly Asp Ile Asn Leu Asp Tyr Gly Gly Thr His Tyr Asn Gln Lys Phe 
1               5                   10                  15      


Lys Gly 
        


<210> 177
<211> 18
<212> PRT
<213> Artificial Sequence

<220>
<221> source
<223> /note="Description of Artificial Sequence: Synthetic
      peptide"

<400> 177
Gly Asp Ile Asn Leu Asp Ser Gly Gly Thr His Tyr Asn Gln Lys Phe 
1               5                   10                  15      


Lys Gly 
        


<210> 178
<211> 18
<212> PRT
<213> Artificial Sequence

<220>
<221> source
<223> /note="Description of Artificial Sequence: Synthetic
      peptide"

<400> 178
Gly Asp Ile Asn Leu Asp Arg Gly Gly Thr His Tyr Asn Gln Lys Phe 
1               5                   10                  15      


Lys Gly 
        


<210> 179
<211> 18
<212> PRT
<213> Artificial Sequence

<220>
<221> source
<223> /note="Description of Artificial Sequence: Synthetic
      peptide"

<400> 179
Gly Asp Ile Asn Leu Asp Lys Gly Gly Thr His Tyr Asn Gln Lys Phe 
1               5                   10                  15      


Lys Gly 
        


<210> 180
<211> 18
<212> PRT
<213> Artificial Sequence

<220>
<221> source
<223> /note="Description of Artificial Sequence: Synthetic
      peptide"

<400> 180
Gly Asp Ile Asn Leu Asp Asn Gly Val Thr His Tyr Asn Gln Lys Phe 
1               5                   10                  15      


Lys Gly 
        


<210> 181
<211> 18
<212> PRT
<213> Artificial Sequence

<220>
<221> source
<223> /note="Description of Artificial Sequence: Synthetic
      peptide"

<400> 181
Gly Asp Ile Asn Leu Asp Asn Gly Ser Thr His Tyr Asn Gln Lys Phe 
1               5                   10                  15      


Lys Gly 
        


<210> 182
<211> 18
<212> PRT
<213> Artificial Sequence

<220>
<221> source
<223> /note="Description of Artificial Sequence: Synthetic
      peptide"

<400> 182
Gly Asp Ile Asn Leu Asp Asn Gly Gly Arg His Tyr Asn Gln Lys Phe 
1               5                   10                  15      


Lys Gly 
        


<210> 183
<211> 18
<212> PRT
<213> Artificial Sequence

<220>
<221> source
<223> /note="Description of Artificial Sequence: Synthetic
      peptide"

<400> 183
Gly Asp Ile Asn Leu Asp Asn Gly Gly Thr His Val Asn Gln Lys Phe 
1               5                   10                  15      


Lys Gly 
        


<210> 184
<211> 18
<212> PRT
<213> Artificial Sequence

<220>
<221> source
<223> /note="Description of Artificial Sequence: Synthetic
      peptide"

<400> 184
Gly Asp Ile Asn Leu Asp Asn Gly Gly Thr His Ile Asn Gln Lys Phe 
1               5                   10                  15      


Lys Gly 
        


<210> 185
<211> 18
<212> PRT
<213> Artificial Sequence

<220>
<221> source
<223> /note="Description of Artificial Sequence: Synthetic
      peptide"

<400> 185
Gly Asp Ile Asn Leu Asp Asn Gly Gly Thr His Leu Asn Gln Lys Phe 
1               5                   10                  15      


Lys Gly 
        


<210> 186
<211> 18
<212> PRT
<213> Artificial Sequence

<220>
<221> source
<223> /note="Description of Artificial Sequence: Synthetic
      peptide"

<400> 186
Gly Asp Ile Asn Leu Asp Asn Gly Gly Thr His Tyr Asn Gln Lys Phe 
1               5                   10                  15      


Lys Arg 
        


<210> 187
<211> 18
<212> PRT
<213> Artificial Sequence

<220>
<221> source
<223> /note="Description of Artificial Sequence: Synthetic
      peptide"

<400> 187
Gly Asp Ile Asn Leu Asp Asn Gly Gly Thr His Tyr Asn Gln Lys Phe 
1               5                   10                  15      


Lys Ser 
        


<210> 188
<211> 16
<212> PRT
<213> Artificial Sequence

<220>
<221> source
<223> /note="Description of Artificial Sequence: Synthetic
      peptide"

<400> 188
Asn Arg Glu Gly Val Tyr His Asp Tyr Asp Asp Tyr Ala Met Asp Tyr 
1               5                   10                  15      


<210> 189
<211> 16
<212> PRT
<213> Artificial Sequence

<220>
<221> source
<223> /note="Description of Artificial Sequence: Synthetic
      peptide"

<400> 189
Thr Arg Glu Gly Val Tyr His Asp Tyr Asp Asp Tyr Ala Met Asp Tyr 
1               5                   10                  15      


<210> 190
<211> 16
<212> PRT
<213> Artificial Sequence

<220>
<221> source
<223> /note="Description of Artificial Sequence: Synthetic
      peptide"

<400> 190
Ala Arg Glu Gly Val Tyr His Pro Tyr Asp Asp Tyr Ala Met Asp Tyr 
1               5                   10                  15      


<210> 191
<211> 16
<212> PRT
<213> Artificial Sequence

<220>
<221> source
<223> /note="Description of Artificial Sequence: Synthetic
      peptide"

<400> 191
Ala Arg Glu Gly Val Tyr His Pro Tyr Asp Asp Tyr Ala Met Asp Tyr 
1               5                   10                  15      


<210> 192
<211> 16
<212> PRT
<213> Artificial Sequence

<220>
<221> source
<223> /note="Description of Artificial Sequence: Synthetic
      peptide"

<400> 192
Ala Arg Glu Gly Val Tyr His Asp Tyr Asp Asp Tyr Ala Trp Asp Tyr 
1               5                   10                  15      


<210> 193
<211> 113
<212> PRT
<213> Homo sapiens

<400> 193
Asp Ile Gln Met Thr Gln Ser Pro Ser Ser Leu Ser Ala Ser Val Gly 
1               5                   10                  15      


Asp Arg Val Thr Ile Thr Cys Arg Thr Ser Gln Ser Leu Val His Ile 
            20                  25                  30          


Asn Gly Ile Thr Tyr Leu His Trp Tyr Gln Gln Lys Pro Gly Lys Ala 
        35                  40                  45              


Pro Lys Leu Leu Ile Tyr Arg Val Ser Asn Arg Phe Ser Gly Val Pro 
    50                  55                  60                  


Ser Arg Phe Ser Gly Ser Gly Ser Gly Thr Asp Phe Thr Leu Thr Ile 
65                  70                  75                  80  


Ser Ser Leu Gln Pro Glu Asp Phe Ala Thr Tyr Tyr Cys Gly Gln Ser 
                85                  90                  95      


Thr His Val Pro Leu Thr Phe Gly Gln Gly Thr Lys Val Glu Ile Lys 
            100                 105                 110         


Arg 
    


<210> 194
<211> 113
<212> PRT
<213> Homo sapiens

<400> 194
Asp Ile Gln Met Thr Gln Ser Pro Ser Ser Leu Ser Ala Ser Val Gly 
1               5                   10                  15      


Asp Arg Val Thr Ile Thr Cys Arg Thr Ser Gln Ser Leu Val His Ile 
            20                  25                  30          


Asn Ala Ile Thr Tyr Leu His Trp Tyr Gln Gln Lys Pro Gly Lys Ala 
        35                  40                  45              


Pro Lys Leu Leu Ile Tyr Arg Val Ser Asn Arg Phe Ser Gly Val Pro 
    50                  55                  60                  


Ser Arg Phe Ser Gly Ser Gly Ser Gly Thr Asp Phe Thr Leu Thr Ile 
65                  70                  75                  80  


Ser Ser Leu Gln Pro Glu Asp Phe Ala Thr Tyr Tyr Cys Gly Gln Ser 
                85                  90                  95      


Thr His Val Pro Leu Thr Phe Gly Gln Gly Thr Lys Val Glu Ile Lys 
            100                 105                 110         


Arg 



<210> 195
<211> 123
<212> PRT
<213> Homo sapiens

<400> 195
Glu Val Gln Leu Val Glu Ser Gly Gly Gly Leu Val Gln Pro Gly Gly 
1               5                   10                  15      


Ser Leu Arg Leu Ser Cys Ala Ala Ser Gly Tyr Thr Phe Ile Asp Tyr 
            20                  25                  30          


Tyr Met Asn Trp Val Arg Gln Ala Pro Gly Lys Gly Leu Glu Trp Val 
        35                  40                  45              


Gly Asp Ile Asn Leu Asp Asn Gly Gly Thr His Tyr Asn Gln Lys Phe 
    50                  55                  60                  


Lys Gly Arg Phe Thr Ile Ser Arg Asp Lys Ser Lys Asn Thr Ala Tyr 
65                  70                  75                  80  


Leu Gln Met Asn Ser Leu Arg Ala Glu Asp Thr Ala Val Tyr Tyr Cys 
                85                  90                  95      


Ala Arg Glu Gly Val Tyr His Asp Tyr Asp Asp Tyr Ala Met Asp Tyr 
            100                 105                 110         


Trp Gly Gln Gly Thr Leu Val Thr Val Ser Ser 
        115                 120             


<210> 196
<211> 123
<212> PRT
<213> Homo sapiens

<400> 196
Glu Val Gln Leu Val Glu Ser Gly Gly Gly Leu Val Gln Pro Gly Gly 
1               5                   10                  15      


Ser Leu Arg Leu Ser Cys Ala Ala Ser Gly Tyr Thr Phe Ile Asp Tyr 
            20                  25                  30          


Tyr Met Asn Trp Val Arg Gln Ala Pro Gly Lys Gly Leu Glu Trp Val 
        35                  40                  45              


Gly Asp Ile Asn Leu Asp Asn Ser Gly Thr His Tyr Asn Gln Lys Phe 
    50                  55                  60                  


Lys Gly Arg Phe Thr Ile Ser Arg Asp Lys Ser Lys Asn Thr Ala Tyr 
65                  70                  75                  80  


Leu Gln Met Asn Ser Leu Arg Ala Glu Asp Thr Ala Val Tyr Tyr Cys 
                85                  90                  95      


Ala Arg Glu Gly Val Tyr His Asp Tyr Asp Asp Tyr Ala Met Asp Tyr 
            100                 105                 110         


Trp Gly Gln Gly Thr Leu Val Thr Val Ser Ser 
        115                 120             


<210> 197
<211> 25
<212> PRT
<213> Homo sapiens

<400> 197
Glu Val Gln Leu Val Glu Ser Gly Gly Gly Leu Val Gln Pro Gly Gly 
1               5                   10                  15      


Ser Leu Arg Leu Ser Cys Ala Ala Ser 
            20                  25  


<210> 198
<211> 13
<212> PRT
<213> Homo sapiens

<400> 198
Trp Val Arg Gln Ala Pro Gly Lys Gly Leu Glu Trp Val 
1               5                   10              


<210> 199
<211> 30
<212> PRT
<213> Homo sapiens

<400> 199
Arg Phe Thr Ile Ser Arg Asp Asn Ser Lys Asn Thr Leu Tyr Leu Gln 
1               5                   10                  15      


Met Asn Ser Leu Arg Ala Glu Asp Thr Ala Val Tyr Tyr Cys 
            20                  25                  30  


<210> 200
<211> 11
<212> PRT
<213> Homo sapiens

<400> 200
Trp Gly Gln Gly Thr Leu Val Thr Val Ser Ser 
1               5                   10      


<210> 201
<211> 23
<212> PRT
<213> Homo sapiens

<400> 201
Asp Ile Gln Met Thr Gln Ser Pro Ser Ser Leu Ser Ala Ser Val Gly 
1               5                   10                  15      


Asp Arg Val Thr Ile Thr Cys 
            20              


<210> 202
<211> 15
<212> PRT
<213> Homo sapiens

<400> 202
Trp Tyr Gln Gln Lys Pro Gly Lys Ala Pro Lys Leu Leu Ile Tyr 
1               5                   10                  15  


<210> 203
<211> 32
<212> PRT
<213> Homo sapiens

<400> 203
Gly Val Pro Ser Arg Phe Ser Gly Ser Gly Ser Gly Thr Asp Phe Thr 
1               5                   10                  15      


Leu Thr Ile Ser Ser Leu Gln Pro Glu Asp Phe Ala Thr Tyr Tyr Cys 
            20                  25                  30          


<210> 204
<211> 11
<212> PRT
<213> Homo sapiens

<400> 204
Phe Gly Gln Gly Thr Lys Val Glu Ile Lys Arg 
1               5                   10      


<210> 205
<211> 30
<212> PRT
<213> Artificial Sequence

<220>
<221> source
<223> /note="Description of Artificial Sequence: Synthetic
      polypeptide"


<220>
<221> VARIANT
<222> (6)..(6)
<223> /replace="Arg"

<220>
<221> misc_feature
<222> (6)..(6)
<223> /note="Residue given in the sequence has no preference
      with respect to those in the annotation for said position"

<220>
<221> VARIANT
<222> (8)..(8)
<223> /replace="Asn"

<220>
<221> misc_feature
<222> (8)..(8)
<223> /note="Residue given in the sequence has no preference
      with respect to those in the annotation for said position"

<220>
<221> VARIANT
<222> (13)..(13)
<223> /replace="Leu"

<220>
<221> misc_feature
<222> (13)..(13)
<223> /note="Residue given in the sequence has no preference
      with respect to those in the annotation for said position"

<400> 205
Arg Phe Thr Ile Ser Ala Asp Thr Ser Lys Asn Thr Ala Tyr Leu Gln 
1               5                   10                  15      


Met Asn Ser Leu Arg Ala Glu Asp Thr Ala Val Tyr Tyr Cys 
            20                  25                  30  


<210> 206
<211> 31
<212> PRT
<213> Homo sapiens

<400> 206
Arg Phe Thr Ile Ser Ala Asp Thr Ser Lys Asn Thr Ala Tyr Leu Gln 
1               5                   10                  15      


Met Asn Ser Leu Arg Ala Glu Asp Thr Ala Val Tyr Tyr Cys Ala 
            20                  25                  30      


<210> 207
<211> 32
<212> PRT
<213> Homo sapiens

<400> 207
Arg Phe Thr Ile Ser Ala Asp Thr Ser Lys Asn Thr Ala Tyr Leu Gln 
1               5                   10                  15      


Met Asn Ser Leu Arg Ala Glu Asp Thr Ala Val Tyr Tyr Cys Ala Arg 
            20                  25                  30          


<210> 208
<211> 31
<212> PRT
<213> Homo sapiens

<400> 208
Arg Phe Thr Ile Ser Ala Asp Thr Ser Lys Asn Thr Ala Tyr Leu Gln 
1               5                   10                  15      


Met Asn Ser Leu Arg Ala Glu Asp Thr Ala Val Tyr Tyr Cys Ser 
            20                  25                  30      


<210> 209
<211> 32
<212> PRT
<213> Homo sapiens

<400> 209
Arg Phe Thr Ile Ser Ala Asp Thr Ser Lys Asn Thr Ala Tyr Leu Gln 
1               5                   10                  15      


Met Asn Ser Leu Arg Ala Glu Asp Thr Ala Val Tyr Tyr Cys Ser Arg 
            20                  25                  30          


<210> 210
<211> 15
<212> PRT
<213> Artificial Sequence

<220>
<221> source
<223> /note="Description of Artificial Sequence: Synthetic
      peptide"


<220>
<221> VARIANT
<222> (2)..(2)
<223> /replace="Arg"

<220>
<221> misc_feature
<222> (2)..(2)
<223> /note="Residue given in the sequence has no preference
      with respect to those in the annotation for said position"

<220>
<221> VARIANT
<222> (4)..(4)
<223> /replace="Gln"

<220>
<221> misc_feature
<222> (4)..(4)
<223> /note="Residue given in the sequence has no preference
      with respect to those in the annotation for said position"

<220>
<221> VARIANT
<222> (6)..(6)
<223> /replace="Val"

<220>
<221> misc_feature
<222> (6)..(6)
<223> /note="Residue given in the sequence has no preference
      with respect to those in the annotation for said position"

<220>
<221> VARIANT
<222> (9)..(9)
<223> /replace="Leu" or "Arg" or "Ser" or "Trp"

<220>
<221> misc_feature
<222> (9)..(9)
<223> /note="Residue given in the sequence has no preference
      with respect to those in the annotations for said position"

<220>
<221> VARIANT
<222> (14)..(14)
<223> /replace="Val"

<220>
<221> misc_feature
<222> (14)..(14)
<223> /note="Residue given in the sequence has no preference
      with respect to those in the annotation for said position"

<400> 210
Lys Ala Ser His Ser Gly Asp Tyr Asp Gly Asp Ser Tyr Met Ser 
1               5                   10                  15  


<210> 211
<211> 7
<212> PRT
<213> Artificial Sequence

<220>
<221> source
<223> /note="Description of Artificial Sequence: Synthetic
      peptide"


<220>
<221> VARIANT
<222> (4)..(4)
<223> /replace="Tyr"

<220>
<221> VARIANT
<222> (5)..(5)
<223> /replace="Arg" or "Tyr"

<220>
<221> misc_feature
<222> (4)..(5)
<223> /note="Residues given in the sequence have no preference
      with respect to those in the annotations for said positions"

<220>
<221> VARIANT
<222> (7)..(7)
<223> /replace="Ser"

<220>
<221> misc_feature
<222> (7)..(7)
<223> /note="Residue given in the sequence has no preference
      with respect to those in the annotation for said position"

<400> 211
Gly Ala Ser Asn Leu Glu Gln 
1               5           


<210> 212
<211> 9
<212> PRT
<213> Artificial Sequence

<220>
<221> source
<223> /note="Description of Artificial Sequence: Synthetic
      peptide"


<220>
<221> VARIANT
<222> (6)..(6)
<223> /replace="Glu"

<220>
<221> misc_feature
<222> (6)..(6)
<223> /note="Residue given in the sequence has no preference
      with respect to those in the annotation for said position"

<220>
<221> VARIANT
<222> (8)..(8)
<223> /replace="Tyr"

<220>
<221> misc_feature
<222> (8)..(8)
<223> /note="Residue given in the sequence has no preference
      with respect to those in the annotation for said position"

<400> 212
Gln Gln Asn Asn Glu Asp Pro Phe Thr 
1               5                   


<210> 213
<211> 10
<212> PRT
<213> Artificial Sequence

<220>
<221> source
<223> /note="Description of Artificial Sequence: Synthetic
      peptide"


<220>
<221> VARIANT
<222> (2)..(2)
<223> /replace="Val"

<220>
<221> VARIANT
<222> (3)..(3)
<223> /replace="Thr"

<220>
<221> VARIANT
<222> (4)..(4)
<223> /replace="Gly" or "Arg" or "Ser"

<220>
<221> VARIANT
<222> (5)..(5)
<223> /replace="Gly" or "Arg" or "Thr"

<220>
<221> misc_feature
<222> (2)..(5)
<223> /note="Residues given in the sequence have no preference
      with respect to those in the annotations for said positions"

<220>
<221> VARIANT
<222> (9)..(9)
<223> /replace="Tyr"

<220>
<221> misc_feature
<222> (9)..(9)
<223> /note="Residue given in the sequence has no preference
      with respect to those in the annotation for said position"

<400> 213
Gly His Arg Phe Asp Thr Tyr Gly Met Ser 
1               5                   10  


<210> 214
<211> 18
<212> PRT
<213> Artificial Sequence

<220>
<221> source
<223> /note="Description of Artificial Sequence: Synthetic
      peptide"


<220>
<221> VARIANT
<222> (5)..(5)
<223> /replace="Met" or "Thr" or "Trp"

<220>
<221> VARIANT
<222> (6)..(6)
<223> /replace="Arg"

<220>
<221> misc_feature
<222> (5)..(6)
<223> /note="Residues given in the sequence have no preference
      with respect to those in the annotations for said positions"

<220>
<221> VARIANT
<222> (12)..(12)
<223> /replace="Met" or "Thr" or "Tyr"

<220>
<221> misc_feature
<222> (12)..(12)
<223> /note="Residue given in the sequence has no preference
      with respect to those in the annotations for said position"

<220>
<221> VARIANT
<222> (14)..(14)
<223> /replace="His"

<220>
<221> VARIANT
<222> (15)..(15)
<223> /replace="Met" or "Thr"

<220>
<221> VARIANT
<222> (16)..(16)
<223> /replace="Tyr"

<220>
<221> VARIANT
<222> (17)..(17)
<223> /replace="Ser"

<220>
<221> VARIANT
<222> (18)..(18)
<223> /replace="Arg"

<220>
<221> misc_feature
<222> (14)..(18)
<223> /note="Residues given in the sequence have no preference
      with respect to those in the annotations for said positions"

<400> 214
Gly Trp Ile Asn Ile His Ser Gly Val Pro Thr Ile Ala Asp Asp Phe 
1               5                   10                  15      


Lys Gly 
        


<210> 215
<211> 10
<212> PRT
<213> Artificial Sequence

<220>
<221> source
<223> /note="Description of Artificial Sequence: Synthetic
      peptide"


<220>
<221> VARIANT
<222> (2)..(2)
<223> /replace="Arg"

<220>
<221> misc_feature
<222> (2)..(2)
<223> /note="Residue given in the sequence has no preference
      with respect to those in the annotation for said position"

<220>
<221> VARIANT
<222> (6)..(6)
<223> /replace="Ser" or "Tyr"

<220>
<221> misc_feature
<222> (6)..(6)
<223> /note="Residue given in the sequence has no preference
      with respect to those in the annotations for said position"

<220>
<221> VARIANT
<222> (10)..(10)
<223> /replace="Tyr"

<220>
<221> misc_feature
<222> (10)..(10)
<223> /note="Residue given in the sequence has no preference
      with respect to those in the annotation for said position"

<400> 215
Ala Asn Leu Gly Ser Cys Ala Val Asp Ala 
1               5                   10  


<210> 216
<211> 25
<212> PRT
<213> Artificial Sequence

<220>
<221> source
<223> /note="Description of Artificial Sequence: Synthetic
      peptide"


<220>
<221> VARIANT
<222> (2)..(2)
<223> /replace="Val"

<220>
<221> misc_feature
<222> (2)..(2)
<223> /note="Residue given in the sequence has no preference
      with respect to those in the annotation for said position"

<400> 216
Glu Ile Gln Leu Val Glu Ser Gly Gly Gly Leu Val Gln Pro Gly Gly 
1               5                   10                  15      


Ser Leu Arg Leu Ser Cys Ala Ala Ser 
            20                  25  


<210> 217
<211> 13
<212> PRT
<213> Artificial Sequence

<220>
<221> source
<223> /note="Description of Artificial Sequence: Synthetic
      peptide"


<220>
<221> VARIANT
<222> (13)..(13)
<223> /replace="Val"

<220>
<221> misc_feature
<222> (13)..(13)
<223> /note="Residue given in the sequence has no preference
      with respect to those in the annotation for said position"

<400> 217
Trp Val Arg Gln Ala Pro Gly Lys Gly Leu Glu Trp Ile 
1               5                   10              


<210> 218
<211> 32
<212> PRT
<213> Artificial Sequence

<220>
<221> source
<223> /note="Description of Artificial Sequence: Synthetic
      polypeptide"


<220>
<221> VARIANT
<222> (4)..(4)
<223> /replace="Ile"

<220>
<221> misc_feature
<222> (4)..(4)
<223> /note="Residue given in the sequence has no preference
      with respect to those in the annotation for said position"

<220>
<221> VARIANT
<222> (6)..(6)
<223> /replace="Arg"

<220>
<221> misc_feature
<222> (6)..(6)
<223> /note="Residue given in the sequence has no preference
      with respect to those in the annotation for said position"

<220>
<221> VARIANT
<222> (8)..(8)
<223> /replace="Thr"

<220>
<221> misc_feature
<222> (8)..(8)
<223> /note="Residue given in the sequence has no preference
      with respect to those in the annotation for said position"

<220>
<221> VARIANT
<222> (10)..(10)
<223> /replace="Glu" or "Lys" or "Thr"

<220>
<221> VARIANT
<222> (11)..(11)
<223> /replace="Ser"

<220>
<221> misc_feature
<222> (10)..(11)
<223> /note="Residues given in the sequence have no preference
      with respect to those in the annotations for said positions"

<220>
<221> VARIANT
<222> (13)..(13)
<223> /replace="Leu" or "Met" or "Thr" or "Val"

<220>
<221> misc_feature
<222> (13)..(13)
<223> /note="Residue given in the sequence has no preference
      with respect to those in the annotations for said position"

<220>
<221> VARIANT
<222> (29)..(29)
<223> /replace="Tyr"

<220>
<221> misc_feature
<222> (29)..(29)
<223> /note="Residue given in the sequence has no preference
      with respect to those in the annotation for said position"

<400> 218
Arg Phe Thr Phe Ser Leu Asp Asn Ser Ala Asn Thr Ala Tyr Leu Gln 
1               5                   10                  15      


Met Asn Ser Leu Arg Ala Glu Asp Thr Ala Val Tyr Phe Cys Ala Arg 
            20                  25                  30          


<210> 219
<211> 11
<212> PRT
<213> Artificial Sequence

<220>
<221> source
<223> /note="Description of Artificial Sequence: Synthetic
      peptide"

<400> 219
Trp Gly Gln Gly Thr Leu Val Thr Val Ser Ser 
1               5                   10      


<210> 220
<211> 32
<212> PRT
<213> Artificial Sequence

<220>
<221> source
<223> /note="Description of Artificial Sequence: Synthetic
      polypeptide"


<220>
<221> VARIANT
<222> (6)..(6)
<223> /replace="Arg"

<220>
<221> misc_feature
<222> (6)..(6)
<223> /note="Residue given in the sequence has no preference
      with respect to those in the annotation for said position"

<220>
<221> VARIANT
<222> (13)..(13)
<223> /replace="Leu" or "Met" or "Thr" or "Val"

<220>
<221> misc_feature
<222> (13)..(13)
<223> /note="Residue given in the sequence has no preference
      with respect to those in the annotations for said position"

<400> 220
Arg Phe Thr Ile Ser Leu Asp Asn Ser Lys Asn Thr Ala Tyr Leu Gln 
1               5                   10                  15      


Met Asn Ser Leu Arg Ala Glu Asp Thr Ala Val Tyr Tyr Cys Ala Arg 
            20                  25                  30          


<210> 221
<211> 10
<212> PRT
<213> Artificial Sequence

<220>
<221> source
<223> /note="Description of Artificial Sequence: Synthetic
      peptide"

<400> 221
Phe Gly Gln Gly Thr Lys Val Glu Ile Lys 
1               5                   10  


<210> 222
<211> 16
<212> PRT
<213> Artificial Sequence

<220>
<221> source
<223> /note="Description of Artificial Sequence: Synthetic
      peptide"


<220>
<221> VARIANT
<222> (1)..(1)
<223> /replace="Gln" or "Arg" or "Ser" or "Thr"

<220>
<221> VARIANT
<222> (2)..(2)
<223> /replace="Thr" or "Trp"

<220>
<221> VARIANT
<222> (3)..(3)
<223> /replace="Ser"

<220>
<221> VARIANT
<222> (4)..(4)
<223> /replace="Gln"

<220>
<221> VARIANT
<222> (5)..(5)
<223> /replace="Ser"

<220>
<221> VARIANT
<222> (6)..(6)
<223> /replace="Val"

<220>
<221> misc_feature
<222> (1)..(6)
<223> /note="Residues given in the sequence have no preference
      with respect to those in the annotations for said positions"

<220>
<221> VARIANT
<222> (8)..(8)
<223> /replace="Pro"

<220>
<221> VARIANT
<222> (9)..(9)
<223> /replace="Leu" or "Pro" or "Thr" or "Tyr"

<220>
<221> VARIANT
<222> (10)..(10)
<223> /replace="Gln" or "Ser"

<220>
<221> VARIANT
<222> (11)..(11)
<223> /replace="Gly" or "Ser"

<220>
<221> misc_feature
<222> (8)..(11)
<223> /note="Residues given in the sequence have no preference
      with respect to those in the annotations for said positions"

<220>
<221> VARIANT
<222> (16)..(16)
<223> /replace="His"

<220>
<221> misc_feature
<222> (16)..(16)
<223> /note="Residue given in the sequence has no preference
      with respect to those in the annotation for said position"

<400> 222
Leu Pro His Asp Gly Leu Val His Ile Asn Ala Ile Thr Tyr Leu Gly 
1               5                   10                  15      


<210> 223
<211> 7
<212> PRT
<213> Artificial Sequence

<220>
<221> source
<223> /note="Description of Artificial Sequence: Synthetic
      peptide"


<220>
<221> VARIANT
<222> (5)..(5)
<223> /replace="Arg"

<220>
<221> VARIANT
<222> (6)..(6)
<223> /replace="Gly" or "Phe" or "Ile" or "Thr"

<220>
<221> misc_feature
<222> (5)..(6)
<223> /note="Residues given in the sequence have no preference
      with respect to those in the annotations for said positions"

<400> 223
Arg Val Ser Asn Asp Ala Ser 
1               5           


<210> 224
<211> 9
<212> PRT
<213> Artificial Sequence

<220>
<221> source
<223> /note="Description of Artificial Sequence: Synthetic
      peptide"


<220>
<221> VARIANT
<222> (1)..(1)
<223> /replace="Gly" or "Ile" or "Lys" or "Leu" or "Asn" or 
      "Ser" or "Thr" or "Val"

<220>
<221> misc_feature
<222> (1)..(1)
<223> /note="Residue given in the sequence has no preference
      with respect to those in the annotations for said position"

<220>
<221> VARIANT
<222> (4)..(4)
<223> /replace="Thr"

<220>
<221> VARIANT
<222> (5)..(5)
<223> /replace="His"

<220>
<221> misc_feature
<222> (4)..(5)
<223> /note="Residues given in the sequence have no preference
      with respect to those in the annotations for said positions"

<400> 224
Ala Gln Ser Cys Phe Val Pro Leu Thr 
1               5                   


<210> 225
<211> 10
<212> PRT
<213> Artificial Sequence

<220>
<221> source
<223> /note="Description of Artificial Sequence: Synthetic
      peptide"


<220>
<221> VARIANT
<222> (3)..(3)
<223> /replace="Thr"

<220>
<221> VARIANT
<222> (4)..(4)
<223> /replace="Val"

<220>
<221> VARIANT
<222> (5)..(5)
<223> /replace="Met" or "Arg" or "Ser"

<220>
<221> misc_feature
<222> (3)..(5)
<223> /note="Residues given in the sequence have no preference
      with respect to those in the annotations for said positions"

<220>
<221> VARIANT
<222> (7)..(7)
<223> /replace="Gln" or "Lys"

<220>
<221> misc_feature
<222> (7)..(7)
<223> /note="Residue given in the sequence has no preference
      with respect to those in the annotations for said position"

<220>
<221> VARIANT
<222> (9)..(9)
<223> /replace="Met"

<220>
<221> misc_feature
<222> (9)..(9)
<223> /note="Residue given in the sequence has no preference
      with respect to those in the annotation for said position"

<400> 225
Gly Tyr Asn Phe Ile Asp Tyr Tyr Ile Asn 
1               5                   10  


<210> 226
<211> 18
<212> PRT
<213> Artificial Sequence

<220>
<221> source
<223> /note="Description of Artificial Sequence: Synthetic
      peptide"


<220>
<221> VARIANT
<222> (5)..(5)
<223> /replace="Leu" or "Asn" or "Pro"

<220>
<221> VARIANT
<222> (6)..(6)
<223> /replace="Leu" or "Arg"

<220>
<221> VARIANT
<222> (7)..(7)
<223> /replace="Lys" or "Asn" or "Arg" or "Ser" or "Tyr"

<220>
<221> VARIANT
<222> (8)..(8)
<223> /replace="Ser"

<220>
<221> VARIANT
<222> (9)..(9)
<223> /replace="Ile" or "Lys" or "Arg" or "Ser" or "Thr" or "Val"

<220>
<221> VARIANT
<222> (10)..(10)
<223> /replace="Arg" or "Thr"

<220>
<221> misc_feature
<222> (5)..(10)
<223> /note="Residues given in the sequence have no preference
      with respect to those in the annotations for said positions"

<220>
<221> VARIANT
<222> (12)..(12)
<223> /replace="Val" or "Tyr"

<220>
<221> VARIANT
<222> (13)..(13)
<223> /replace="Ser"

<220>
<221> VARIANT
<222> (14)..(14)
<223> /replace="Asn" or "Gln"

<220>
<221> VARIANT
<222> (15)..(15)
<223> /replace="Val"

<220>
<221> VARIANT
<222> (16)..(16)
<223> /replace="Gln"

<220>
<221> VARIANT
<222> (17)..(17)
<223> /replace="Thr"

<220>
<221> VARIANT
<222> (18)..(18)
<223> /replace="His" or "Arg" or "Ser"

<220>
<221> misc_feature
<222> (12)..(18)
<223> /note="Residues given in the sequence have no preference
      with respect to those in the annotations for said positions"

<400> 226
Gly Asp Ile Asn Ala Asp Gly Gly Gly Gly His Ile Asn Ala Lys Phe 
1               5                   10                  15      


Lys Gly 
        


<210> 227
<211> 16
<212> PRT
<213> Artificial Sequence

<220>
<221> source
<223> /note="Description of Artificial Sequence: Synthetic
      peptide"


<220>
<221> VARIANT
<222> (1)..(1)
<223> /replace="Asn" or "Thr"

<220>
<221> misc_feature
<222> (1)..(1)
<223> /note="Residue given in the sequence has no preference
      with respect to those in the annotations for said position"

<220>
<221> VARIANT
<222> (8)..(8)
<223> /replace="Pro"

<220>
<221> misc_feature
<222> (8)..(8)
<223> /note="Residue given in the sequence has no preference
      with respect to those in the annotation for said position"

<220>
<221> VARIANT
<222> (14)..(14)
<223> /replace="Trp"

<220>
<221> misc_feature
<222> (14)..(14)
<223> /note="Residue given in the sequence has no preference
      with respect to those in the annotation for said position"

<400> 227
Ala Arg Glu Gly Val Tyr His Asp Tyr Asp Asp Tyr Ala Met Asp Tyr 
1               5                   10                  15      


<210> 228
<211> 13
<212> PRT
<213> Artificial Sequence

<220>
<221> source
<223> /note="Description of Artificial Sequence: Synthetic
      peptide"


<220>
<221> VARIANT
<222> (13)..(13)
<223> /replace="Val"

<220>
<221> misc_feature
<222> (13)..(13)
<223> /note="Residue given in the sequence has no preference
      with respect to those in the annotation for said position"

<400> 228
Trp Val Arg Gln Ala Pro Gly Lys Gly Leu Glu Trp Ile 
1               5                   10          


<210> 229
<211> 30
<212> PRT
<213> Artificial Sequence

<220>
<221> source
<223> /note="Description of Artificial Sequence: Synthetic
      polypeptide"


<220>
<221> VARIANT
<222> (2)..(2)
<223> /replace="Val"

<220>
<221> misc_feature
<222> (2)..(2)
<223> /note="Residue given in the sequence has no preference
      with respect to those in the annotation for said position"

<220>
<221> VARIANT
<222> (4)..(4)
<223> /replace="Leu"

<220>
<221> misc_feature
<222> (4)..(4)
<223> /note="Residue given in the sequence has no preference
      with respect to those in the annotation for said position"

<220>
<221> VARIANT
<222> (6)..(6)
<223> /replace="Arg" or "Val"

<220>
<221> misc_feature
<222> (6)..(6)
<223> /note="Residue given in the sequence has no preference
      with respect to those in the annotations for said position"

<220>
<221> VARIANT
<222> (8)..(8)
<223> /replace="Asn"

<220>
<221> misc_feature
<222> (8)..(8)
<223> /note="Residue given in the sequence has no preference
      with respect to those in the annotation for said position"

<220>
<221> VARIANT
<222> (10)..(10)
<223> /replace="Asn" or "Arg" or "Ser"

<220>
<221> VARIANT
<222> (11)..(11)
<223> /replace="Ser"

<220>
<221> misc_feature
<222> (10)..(11)
<223> /note="Residues given in the sequence have no preference
      with respect to those in the annotations for said positions"

<220>
<221> VARIANT
<222> (13)..(13)
<223> /replace="Leu" or "Val"

<220>
<221> misc_feature
<222> (13)..(13)
<223> /note="Residue given in the sequence has no preference
      with respect to those in the annotations for said position"

<220>
<221> VARIANT
<222> (15)..(15)
<223> /replace="Met"

<220>
<221> misc_feature
<222> (15)..(15)
<223> /note="Residue given in the sequence has no preference
      with respect to those in the annotation for said position"

<400> 229
Arg Phe Thr Ile Ser Leu Asp Lys Ser Lys Asn Thr Ala Tyr Leu Gln 
1               5                   10                  15      


Met Asn Ser Leu Arg Ala Glu Asp Thr Ala Val Tyr Tyr Cys 
            20                  25                  30  


<210> 230
<211> 32
<212> PRT
<213> Artificial Sequence

<220>
<221> source
<223> /note="Description of Artificial Sequence: Synthetic
      polypeptide"


<220>
<221> VARIANT
<222> (8)..(8)
<223> /replace="Lys"

<220>
<221> misc_feature
<222> (8)..(8)
<223> /note="Residue given in the sequence has no preference
      with respect to those in the annotation for said position"

<220>
<221> VARIANT
<222> (13)..(13)
<223> /replace="Leu" or "Val"

<220>
<221> misc_feature
<222> (13)..(13)
<223> /note="Residue given in the sequence has no preference
      with respect to those in the annotations for said position"

<400> 230
Arg Phe Thr Ile Ser Arg Asp Asn Ser Lys Asn Thr Ala Tyr Leu Gln 
1               5                   10                  15      


Met Asn Ser Leu Arg Ala Glu Asp Thr Ala Val Tyr Tyr Cys Ala Arg 
            20                  25                  30          


<210> 231
<211> 30
<212> PRT
<213> Homo sapiens

<400> 231
Arg Phe Thr Ile Ser Ala Asp Thr Ser Lys Asn Thr Ala Tyr Leu Gln 
1               5                   10                  15      


Met Asn Ser Leu Arg Ala Glu Asp Thr Ala Val Tyr Tyr Cys 
            20                  25                  30  


<210> 232
<211> 6
<212> DNA
<213> Unknown

<220>
<221> source
<223> /note="Description of Unknown: Eukaryotic sequence"

<220>
<221> modified_base
<222> (2)..(2)
<223> a, c, t, g, unknown or other

<400> 232
cncaat                                                                   6


<210> 233
<211> 6
<212> DNA
<213> Unknown

<220>
<221> source
<223> /note="Description of Unknown: Eukaryotic sequence"

<400> 233
aataaa                                                                   6


